Healthy Mothers -Healthy Children  Version 2  
Protocol  2019 -06-19 
NIH Behavioral and Social Intervention  Clinical Trial Protocol Template v3.0 - 20180827  
a Revision History of this Protocol Template : 
Version Information  Summary of Revisions Made  Rationale  
Version 2.0 – Approved by 
Principal Investigator, Co -
Investigators and Consultants  Expanded ages of children to 3 to 5 
years old   To increase the study sample  

Healthy Mothers -Healthy Children   Version 2  
Protocol   2019 -06-19 
 
 Healthy Mothers -Healthy Children  
Protocol Number :  
National Clinical T rial (NCT) Identified Number: [STUDY_ID_REMOVED] (March  7, 2019)  
Principal Investigator : Dr. Hudson Santos  
Sponsor: The National Institute of Nursing Research  
Grant Title: Healthy Mothers – Healthy Children: An Intervention with Hispanic 
Mothers and their Young Children  
Grant Number : 1R01NR017199 -01 
Funded by : The National Institute of Nursing Research  
Version Number: 2  
2019 -06-19 

Healthy Mothers -Healthy Children   Version 2  
Protocol   2019 -06-19 
NIH Behavioral and Social Intervention Clinical Trial Protocol Template v3.0 - 20180827  
ii 
  
Summary of Changes  from Previous Version:  
 
Affected 
Section(s)  Summary of Revisions Made  Rationale  
Sample  Changed age of children from 4 year 
old to 3 to 5 year olds  To increase sample age range  
 
  

Healthy Mothers -Healthy Children   Version 2  
Protocol   2019 -06-19 
NIH Behavioral and Social Intervention Clinical Trial Protocol Template v3.0 - 20180827  
iii 
 CONFIDENTIALITY STATEMENT  
This document is confidential communication. Acceptance of this document constitutes 
agreement by the recipient that no unpublished information contained herein will be published or 
disclosed without prior approval  of the Principal Investigator  or other participating study leadership 
and as consistent with the NIH terms of award.  
 

Healthy Mothers -Healthy Children   Version 2  
Protocol   2019 -06-19 
 
NIH Behavioral and Social Intervention Clinical Trial Protocol Template v3.0 - 20180827  
iv 
 Table of Contents  
STATEMENT OF COMPLIANCE  ................................ ................................ ................................ .............................  1 
INVESTIGATOR’S SIGNATURE  ................................ ................................ ................................ ..............................  2 
1 PROTOCOL SUMMARY  ................................ ................................ ................................ ...............................  3 
1.1 Synopsis  ................................ ................................ ................................ ................................ ................  3 
1.2 Schema  ................................ ................................ ................................ ................................ .................  3 
1.3 Schedule of Activities  ................................ ................................ ................................ ..........................  5 
2 INTRODUCTION  ................................ ................................ ................................ ................................ ............  6 
2.1 Study Rationale  ................................ ................................ ................................ ................................ .... 6 
2.2 Background ................................ ................................ ................................ ................................ ...........  6 
2.3 Risk/Benefit Assessment  ................................ ................................ ................................ ....................  7 
2.3.1  Known Potential Risks  ................................ ................................ ................................ ..... 7 
2.3.2  Known Potential Benefits  ................................ ................................ ..............................  10 
2.3.3  Assessment of Potential Risks and Benefits  ................................ ..............................  11 
3 OBJECTIVES AND ENDPOINTS  ................................ ................................ ................................ ..............  11 
4 STUDY DESIGN  ................................ ................................ ................................ ................................ ...........  12 
4.1 Overall Design  ................................ ................................ ................................ ................................ .... 12 
4.2 Scientific Rationale for Study Design ................................ ................................ ..............................  12 
4.3 Justification for Intervention  ................................ ................................ ................................ .............  12 
4.4 End-of-Study Definition  ................................ ................................ ................................ .....................  12 
5 STUDY POPULATION  ................................ ................................ ................................ ................................  13 
5.1 Inclusion Criteria  ................................ ................................ ................................ ................................  13 
5.2 Exclusion Criteria  ................................ ................................ ................................ ...............................  13 
5.3 Lifestyle Considerations  ................................ ................................ ................................ ....................  14 
5.4 Screen Failures  ................................ ................................ ................................ ................................ .. 14 
5.5 Strategies for Recruitment and Retention  ................................ ................................ ......................  14 
6 STUDY INTERVENTION(S) OR EXPERIMENTAL MANIPULATION(S)  ................................ ............  15 
6.1 Study Intervention(s) or Experimental Manipulation(s) Administration  ................................ ...... 15 
6.1.1  Study Intervention or Experimental Manipulation Descriptio n ................................ . 15 
6.1.2  Administration and/or Dosing  ................................ ................................ .......................  17 
6.2 Fidelity  ................................ ................................ ................................ ................................ .................  17 
6.2.1  Interventionist Training and Tracking  ................................ ................................ ..........  17 
6.3 Measures to Minimize Bias: Randomization and Blinding  ................................ ...........................  17 
6.4 Study Intervention/Experimental Manipulation Adherence ................................ ..........................  17 
6.5 Concomitant Therapy  ................................ ................................ ................................ ........................  17 
6.5.1  Rescue Therapy  ................................ ................................ ................................ .............  18 
7 STUDY INTERVENTION/EXPERIMENTAL MANIPULATION DISCONTINUATION AND 
PARTICIPANT DISCONTINUATION/W ITHDRAWAL  ................................ ................................ .........................  18 
7.1 Discontinuation of Study Intervention/Experimental  Manipulation  ................................ .............  18 
7.2 Participant Discontinuation/Withdrawal from the Study  ................................ ...............................  18 
7.3 Lost to Follow -Up ................................ ................................ ................................ ...............................  18 
8 STUDY ASSESSMENTS AND PROCEDURES  ................................ ................................ .....................  18 
8.1 Endpoint and Other Non -Safety Assessments  ................................ ................................ ..............  19 
8.2 Safety Assessments  ................................ ................................ ................................ ..........................  19 
8.3 Adverse Events and Serious Adverse Events  ................................ ................................ ...............  19 
8.3.1  Definition of Adverse Events  ................................ ................................ ........................  19 

Healthy Mothers -Healthy Children   Version 2  
Protocol   2019 -06-19 
 
NIH Behavioral and Social Intervention Clinical Trial Protocol Template v3.0 - 20180827  
v 
 8.3.2  Definition of Serious Adverse Events  ................................ ................................ ..........  19 
8.3.3  Classification of an Adverse Event  ................................ ................................ ..............  19 
8.3.4  Time Period and Frequency for Event Assessment and Follow -Up .......................  25 
8.3.5  Adverse Event Reporting  ................................ ................................ ..............................  25 
8.3.6  Serious Adverse Event Reporting  ................................ ................................ ...............  26 
8.3.7  Reporting Events to Participants  ................................ ................................ .................  26 
8.3.8  Events of Special Interest  ................................ ................................ .............................  26 
8.3.9  Reporting of Pregnancy  ................................ ................................ ................................  26 
8.4 Unanticipated Problems  ................................ ................................ ................................ ....................  26 
8.4.1  Definition of Unanticipated Problems  ................................ ................................ ..........  26 
8.4.2  Unanticipated Problems Reporting  ................................ ................................ ..............  26 
8.4.3  Reporting Unanticipated Problems to Participants  ................................ ...................  26 
9 STATISTICAL CONSIDERATIONS  ................................ ................................ ................................ ..........  26 
9.1 Statistical Hypotheses  ................................ ................................ ................................ .......................  26 
9.2 Sample Size Determination  ................................ ................................ ................................ ..............  27 
9.3 Populations for Analyses  ................................ ................................ ................................ ..................  28 
9.4 Statistical Analyses ................................ ................................ ................................ ............................  28 
9.4.1  General Approach  ................................ ................................ ................................ ..........  28 
9.4.2  Analysis of the Primary Endpoint(s)  ................................ ................................ ............  28 
9.4.3  Analysis of the Secondary Endpoint(s)  ................................ ................................ .......  28 
9.4.4  Safety Analyses  ................................ ................................ ................................ ..............  28 
9.4.5  Baseline Descriptive Statistics  ................................ ................................ .....................  28 
9.4.6  Planned Interim Analyses  ................................ ................................ .............................  28 
9.4.7  Sub-Group Analyses  ................................ ................................ ................................ ..... 28 
9.4.8  Tabulation of Individual Participant Data  ................................ ................................ .... 28 
9.4.9  Exploratory Analyses  ................................ ................................ ................................ ..... 28 
10 SUPPORTING DOCUMENTATION AND OPERATIONAL CONSIDERATIONS  ..............................  29 
10.1  Regulatory, Ethical, and Study Oversight Considerations  ................................ ...........................  29 
10.1.1  Informed Consent Process  ................................ ................................ ...........................  29 
10.1.2  Study Discontinuation and Closure  ................................ ................................ .............  30 
10.1.3  Confidentiality and Privacy  ................................ ................................ ...........................  30 
10.1.4  Future Use of Stored Specimens and Data  ................................ ...............................  31 
10.1.5  Key Roles and Study Governance  ................................ ................................ ..............  31 
10.1.6  Safety Oversight  ................................ ................................ ................................ .............  31 
10.1.7  Clinical Monitoring  ................................ ................................ ................................ ..........  31 
10.1.8  Quality Assurance and Quality Control  ................................ ................................ .......  31 
10.1.9  Data Handling and Record Keeping  ................................ ................................ ............  32 
10.1.10  Protocol Deviations  ................................ ................................ ................................ ........  33 
10.1.11  Publication and Data Sharing Policy  ................................ ................................ ...........  33 
10.1.12  Conflict of Interest Policy  ................................ ................................ ..............................  33 
10.2  Additional Considerations  ................................ ................................ ................................ .................  33 
10.3  Abbreviations and Special Terms  ................................ ................................ ................................ ... 33 
10.4  Protocol Amendment History  ................................ ................................ ................................ ...........  35 
11 REFERENCES  ................................ ................................ ................................ ................................ .............  36 
 

Healthy Mothers -Healthy Children   Version 2  
Protocol   2019 -06-19 
 
NIH Behavioral and Social Intervention Clinical Trial Protocol Template v3.0 - 20180827  
  1 STATEMENT OF COMPLIANCE  
 
The trial will be carried out in accordance with International Council on Harmonisation  Good  
Clinical Practice ( ICH GCP) and the following :  
 
• United States (US) Code of Federal Regulations (CFR) applicable to clinical studies (45 CFR Part 
46, 21 CFR Part 50, 21 CFR Part 56, 21 CFR Part 312, and/or 21 CFR Part 812) .  
 
National Institutes of Health ( NIH)-funded investigators and clinical trial site staff who are responsible for 
the conduct, management, or oversight of NIH -funded clinical trials  have com pleted Human Subjects 
Protection and ICH GCP Training.  
 
The protocol, informed consent form(s), recruitment materials, and all participant materials will be 
submitted to the IRB for review and approval. Approval of both the protocol and the consent form (s) must 
be obtained before any participant is consented . Any amendment to the protocol will require review and 
approval by the IRB before the changes are implemented to the study. All changes to the consent form (s) 
will be IRB approved; a determination will be made regarding whether a new consent needs to be 
obtained from participants who provided consent, using a previously approved consent form.  
  

Healthy Mothers -Healthy Children   Version 2  
Protocol   2019 -06-19 
 
NIH Behavioral and Social Intervention Clinical Trial Protocol Template v3.0 - 20180827  
  2 INVESTIGATOR’S SIGNATURE  
The signature below constitutes the approval of this protocol and provides the necessary assurances that this 
study will be conducted according to all stipulations of the protocol, including all statements regarding 
confidentiality, and according to local legal and regulatory requirements an d applicable US federal regulations 
and ICH guidelines.  
 
Principal Investigator or Clinical Site Investigator:  
Signed:  
 Date:  2019-06-19 
 Name:  Dr. Hudson Santos  
 Title:  Principal Investigator  
 
Investigator Contact Information  
Affiliation:  The University of North Carolina at Chapel Hill School of Nursing  
Address:  Campus Box 7460  
Telephone : 919-259-4812  
Email:  hsantosj @email.unc.edu  
 
 
  

Healthy Mothers -Healthy Children   Version 2  
Protocol   2019 -06-19 
 
NIH Behavioral and Social Intervention Clinical Trial Protocol Template v3.0 - 20180827  
  3 1 PROTOCOL SUMMARY  
1.1 SYNOPSIS   
 
Title:  Healthy Mothers -Healthy Children: An Intervention with Hispanic 
Mothers and their Young Children  
Grant Number:  1R01NR017199 -01 
Study Description : This study will use a two -group randomized repeated measures 
study design to evaluate the efficacy of the intervention with 294 
dyads of overweight or obese Hispanic mothers and their 3 -5 year 
old children.  
Objectives:  Primary Objective s: Adiposity and weight in mothers and children 
from Time 1 (baseline) to Time 2 (9 months) and Time 3 (15 
months).  
Secondary Objectives: Health behaviors in mothers and children 
from Time 1 (baseline) to Time 2 (9 months) and Time 3 (15 
months).  
Endpoint s: Primary Endpoint:  Adiposity and weight in mothers and children 
from Time 1 (baseline) to Time 2 (9 months) and Time 3 (15 
months).  
Secondary Endpoints:  Health behaviors in mothers and children 
from Time 1 (baseline) to Time 2 (9 months) and Time 3 (15 
months).  
Study Population:  A total of 294 Hispanic mothers and 294 Hispanic 3 -5 year old 
children from two counties in North Carolina.   
Phase  or Stage:  Randomized controlled trial with an experimental and equal 
attention control group.  
Description of 
Sites /Facilities  Enrolling 
Participants : Two public health departments and two community health centers 
in two counties in North Carolina.  
A total of 294 mothers and their 294 children ages 3 -5 years old.  
Description of Study  
Intervention /Experimental 
Manipulation : An experimental group of women receive a nutrition, exercise and 
coping skills training and physical activity intervention. An 
experimental group of children receive Color Me Healthy classes. 
An equal attention control group women receive English for Secon d 
Language classes and the children have books read to them and 
they color with crayons.  
Study Duration:  A total of 5 years or 60 months.  
Participa nt Duration:  Each par ticipant will be in the study a total of 15 months.  
 
 
 
 
 
 
 
 
  
1.2 SCHEMA   

Healthy Mothers -Healthy Children   Version 2  
Protocol   2019 -06-19 
 
NIH Behavioral and Social Intervention Clinical Trial Protocol Template v3.0 - 20180827  
  4  
Flow Diagram  
 
Pre-Screening  
 
 
 
 
Visit 1  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  Total N: 294 mother child dyads  
Pre-screen potential participants  by inclusion and exclusion criteria  
Conduct informed consent process. Perform baseline assessments.  
Final Assessment  at 15 months   
Arm 2  
N = 147  Arm 1  
N = 147 
dyadmothers   
Administer study intervention and equal attention control group sessions 1 -12 weekly  Randomize  
Administer study intervention and equal attention control group sessions 13 -18 monthly  
Post -Intervention assessment at 9 months  

Healthy Mothers -Healthy Children   Version 2  
Protocol   2019 -06-19 
 
NIH Behavioral and Social Intervention Clinical Trial Protocol Template v3.0 - 20180827  
  5 1.3 SCHEDULE OF ACTIVITIES  
 
Variables and Their Measurement  Respondent  Time 1  Time 2  Time 3  
Short Acculturation Questionnaire for Hispanics  Mother  X   
Health History Questionnaire  Mother  X   
Sports Physical  Mother  X   
Adiposity (Primary Outcomes)      
   Waist Circumference  Mother/Child  X X X 
   Triceps and Subscapular Skinfolds  Mother/Child  X X X 
Weight Status (Primary Outcomes)      
   Height/Weight  Mother/Child  X X X 
   BMI/BMI Percentile  Mother/Child  X X X 
Health Behavior      
   Adult Health Behavior Survey  Mother  X X X 
   Health Promoting Lifestyle Profile II  Mother  X X X 
   24-hour Food Recall for 3 days  Mother for Self/Child  X X X 
   Accelerometer for 7 days  Mother for Self/Child  X X X 
Self-Efficacy      
   Eating Self -Efficacy Scale  Mother  X X X 
   Exercise Self -Efficacy Scale  Mother  X X X 
Demographic Data  Mother for Self/Child  X   
Health History Update Questionnaire  Mother for Self/ Child   X X 
Process Evaluation Bi -Monthly  Project Manager     
Exit Interviews  Mother    X 
Time 1 (0 months [baseline] ) 
Time 2 (9 months [completion of th e intervention])  
Time 3 (15 months [after 6 months with no contact from the study staff])  
  

Healthy Mothers -Healthy Children   Version 2  
Protocol   2019 -06-19 
 
NIH Behavioral and Social Intervention Clinical Trial Protocol Template v3.0 - 20180827  
  6 2  INTRODUCTIO N 
 
2.1 STUDY R ATIONALE   
Background:  Hispanic women and children who become overweight or obese are at risk for developing 
prediabetes, type 2 diabetes, and cardiovascular disease later in life. Interdisciplinary interventions which 
target Hispanic women and their 3 -5-year old children to im prove nutrition and physical activity behaviors, 
manage adiposity and weight in mothers, and prevent excessive adiposity and weight gain trajectory in their 
children offer promise to break the intergenerational cycle.  
Methods:  Using a randomized two -group , repeated measures experimental design, the goal of the proposed 
study is to investigate the efficacy of a 12 -week nutrition and physical activity program including education, 
coping skills training, and home -based intervention in Hispanic women and their  3-5-year old children. The 
program includes 6 months of continued monthly contact to help overweight and obese Hispanic mothers and 
their children improve adiposity, weight (trajectory for children), health behaviors (nutrition and physical 
activity), and  self-efficacy We will partner with two federally qualified health departments in Durham and 
Chatham counties, North Carolina to enroll participants. We will partner with community centers to deliver the 
intervention. A total of 294 Hispanic women with a B MI>25 kg/m2 and 294 Hispanic 3 -5-year old children with a 
>25th BMI percentile will be enrolled over 4 years and randomized to the experimental or equal attention control 
group. Data will be collected at Time 1 (0 months [baseline]) to Time 2 (9 months [co mpletion of the 
intervention]) and Time 1 to Time 3 (15 months [after 6 months with no contact from the study staff]). Data 
collected will include adiposity in mothers and children and weight (primary outcomes: BMI in mothers and BMI 
percentile in the chil dren). Secondary outcomes will include health behaviors and self -efficacy in the mothers 
and in the children. We will also evaluate the cost of delivering the program for public health departments. We 
will use general linear mixed models to test the hypoth eses.  
Discussion:  Decreasing overweight and obesity in Hispanic women and slowing adiposity and weight gain 
trajectory in young Hispanic children is urgently needed to decrease morbidity, mortality, and future health care 
costs.  
2.2 BACKGROUND   
 
There is an urgent need to prevent excessive adiposity and weight gain trajectory in Hispanic children. 
Overweight ( BMI > 85th and < 95th percentile)  and obesity ( > 95th percentile)  are prevalent in both genders, 
affect all ages, and cross all ethnic groups, though minority children from families with lower incomes and less 
education are particularly high -risk [1]. The prevalence of overweight and obesity in 2 -to-19 year old Hispanic 
youth is 38.9%, non -Hispanic Black youth is 35.2%, and non -Hispanic White youth is 28.5% [1]. Obesity 
increases risk for developing prediabetes, type 2 diabetes and cardiovascular disease [2, 3]. Childhood obe sity 
is estimated to cost $14 billion annually in direct medical costs in the United States (U.S.) [4, 5].  
 
There are currently 55.3 million Hispanics living in the U.S. [6]. In 2014, Hispanics accounted for 9% of the 
population in N.C. [6]. Overweight and obesity in Hispanic mothers and their children involve a complex 
interplay between acculturation, the food environment, the built environment, the influence of media, and a lack 
of support  [7]. Many Hispanic men work long hours, while mothers stay home to care for their children without 
close family support [7]. Greater acculturation is significantly associated with increased consumption of fast 
foods and decreased moderate -to-high intensity exercise [8, 9]. Many communities where Hispanics li ve lack 
access to healthy affordable food and have only one -third as many supermarkets as other communities [10]. 
Confronted with an abundance of low cost, calorie -dense, high fat food, and limite d access to fresh produce. 
Hispanics increase their intake of calories and fat and decrease their intake of fruits and vegetables [7, 11].  

Healthy Mothers -Healthy Children   Version 2  
Protocol   2019 -06-19 
 
NIH Behavioral and Social Intervention Clinical Trial Protocol Template v3.0 - 20180827  
  7  
Transportation, infrastructure, and safety issues limit Hispanic mothers’ and children’s options for physical 
activity. Mothers engage in less physical activity than in their home country where most did not own cars, 
televisions, or computers and they were  more likely to include physical activity in their everyday life [7, 11]. 
Hispanic parents also report barriers to their children’s physical activity [12], including neighborhood safety and 
transportation problems [12]. Hispanic children (25.9%) are less likely than non -Hispanic White children 
(46.6%) to be involved in organized physical activity  outside of school [12]. The media also contributes to the 
lack of healthy eating and physical activity. In 2015, advertisers spent more than $7.8 billion on restaurant, 
food, and beverage advertising targeting Hisp anic households [13]. Hispanic children spend more time 
watching television than non -Hispanic White children (321 minutes per day versus 216 minutes) [14], and the 
number of hours spent watching television is positively associated with overweight and obesity [15, 16].  
 
Mothers influence children’s nutrition and physical activity behaviors by modeling health behaviors, structuring 
children’s activities, and selecting content and portion sizes of meals [17-20]. Mothers have more  influence 
when children are in the preschool stage than in later stages of development [21]. Four year olds are able to 
pay attention to activities, think in logical steps, have good language skills, run, jump, skip, and socially and 
emotionally they start to share, cooper ate and take turns [22]. We propose to teach mothers strategies to 
improve their own nutrition and physical activity behaviors, build their self -efficacy, and learn how to help their 
children eat healthier and increase physical activity. We will focus on 3-5-year-olds because our pilot work 
indicates  that they are developmentally more prepared for intervention than younger children [23]. 
 
Nutrition and physical activity programs used in the general population that were found to be most effective 
incorporated both behavioral and cognitive strategies and included parental involvement [19, 24, 25]. To date, 
we have found no interventions that have been developed to help overweight or obese Hispanic mother s 
manage their weight and prevent excessive adiposity and weight gain trajectory in their young children using a 
culturally and language tailored intervention.  We propose to test the efficacy of a nutrition and physical activity 
education, coping skills tr aining, and physical activity intervention ( Healthy Mothers -Healthy Children 
Intervention) tailored to Hispanic mothers and using an age -appropriate nutrition and physical activity 
intervention for their 3-5-year-old children (Color Me Healthy) [26]. Coping skills training includes social 
problem solving, cognitive restructuring, assertiveness training and conflict resolution to improve self -efficacy 
[27-31]. We will provide support as mothers they increase their self -efficacy and practice new nutrition and 
physical activity behaviors and help their children eat healthier and increase phys ical activity.  
 
2.3 RISK/BENEFIT ASSESSMENT   
 
2.3.1  KNOWN  POTENTIAL RISKS  
 
Risks to Human Subjects  
 
Human Subjects Involvement, Characteristics, and Design  
 
Institutional Review Board (IRB) approval was obtained from The University of North Carolina at  
Chapel Hill (UNC -CH). Using a randomized two -group, repeated measures experimental design, the goal of 
the proposed study is to investigate the efficacy of a 12 -week nutrition and exercise education, physical 
activity, coping skills training, and home -base d exercise intervention in Hispanic women and their 3 -5-year old 
children and 6 months of continued monthly contact to help overweight and obese Hispanic mothers improve 
adiposity, weight, health behaviors and self -efficacy and their 3 -5-year old children improve their adiposity and 
weight gain trajectory. We will partner with two federally qualified health departments in two North Carolina 

Healthy Mothers -Healthy Children   Version 2  
Protocol   2019 -06-19 
 
NIH Behavioral and Social Intervention Clinical Trial Protocol Template v3.0 - 20180827  
  8 counties to enroll Hispanic women and their 3 -5-year old children and we will partner with community centers 
to delive r the intervention.  
 
Inclusion criteria for mothers will be age 18 years or older; self -identification as Hispanic heritage; limited  
English proficiency and little acculturation, as measured by the Short Acculturation Scale for Hispanics with a 
score from 1.00 to 2.99; ability to understand spoken Spanish; a BMI >25kg/m 2; residence with the child; 
consent to join the study and consent for their child to join the study. Inclusion criteria for children will be age 3 -
5-years; ability to understand spoken Spani sh; a BMI > 25 th percentile for age and gender; and mother’s 
consent for them to join the study. Health care providers will not be asked to give permission for either mothers 
or children to join the study. Mothers will fill out a health history questionnai re to ascertain if they have a heart 
murmur, congenital heart disease, family history of sudden death, difficulty walking or exercising or history of 
psychological problems that would prevent participation in group classes. A sports physical will be conduc ted 
by a bilingual nurse practitioner on all mothers during baseline data collection to ensure that they have no 
medical problems that would prohibit physical activity. If a mother answers yes to any of these health history 
questions or the nurse practitio ner finds a heart murmur or any other concerns, she will be excluded from the 
study and referred to a health care provider. Dyads will be enrolled in eight cohorts over four years. Each 
cohort will be enrolled over a 1 -month period. We have not included fa thers, as in previous studies in this 
population we have learned the majority of these fathers work 6 days a week and do not have the time to 
attend class with their child. After enrollment and baseline assessment, dyads will be randomized to either the 
intervention or control group using a computer -generated randomization table, stratifying by BMI group, 
overweight (<30 kg/m 2) and obese (>30kg/m 2), and utilizing blocking to help ensure balance between the 
groups. Mothers will be informed of their group ass ignment by telephone.  
 
Data will be collected at Time 1 (Baseline [0 months]), Time 2 (Post Intensive Intervention and  
Continued Support [9 months]), and Time 3 (6 -Months after Completion of Continued Support [15 months]).  
Data collected will include adiposity (primary outcome) in mothers and children (waist circumference, triceps 
and subscapular skinfolds), weight status (primary outcome) in the mothers (body mass index [BMI]) and  
BMI percentile in the children, health behaviors in the mothers  (Adult Health Behavior Questionnaire,  
Lifestyle Health Promoting Profile II, 3 day 23 -5-Hour Food Recall, and 7 day Accelerometer) and in the 
children (3 day 24 -Hour Food Recall and 7 day Accelerometer). Self -Efficacy in the mothers (Eating Self - 
Efficacy  Scale and Exercise Self -Efficacy Scale) will also be measured. We will also evaluate the cost of 
delivering the program for public health departments. Data analysis will use general linear mixed models to test 
the hypotheses. Both intervention and control  group mothers will each receive $50 after each data collection  
and $5 each time they come to class or data collection to help with transportation costs . 
 
The mothers in the Healthy Mothers -Healthy Children Intervention group will receive a 12 week Intensi ve 
Intervention and 6 months of Continued Support. The Intensive Intervention will include 60 minutes of nutrition 
and exercise education and coping skills training and a 45 minute physical activity class and a home -based 
physical activity program each wee k for 12 weeks. The Continued Support classes for the mothers in the 
intervention group will include 60 minutes of classroom discussion regarding problems they are having with 
nutrition and physical activity for themselves and their children and a 45 minut e physical activity class monthly 
for 6 months. The children in the intervention group will receive an Intensive Intervention (105 minutes total), 
which will include 60 minutes of Color Me Healthy classes and 45 minutes of free play weekly for 12 weeks. 
The Continued Support classes for the intervention children will include a review of the Color Me Healthy 
classes and 45 minutes of free play monthly for 6 months. Each weekly or monthly class for mothers and 
children is a total of 105 minutes.  
 
The equal attention control group mothers will receive English as a Second Language (ESL) classes for  
105 minutes for 12 weekly classes and then monthly classes for 6 more months. The equal attention control 
group mothers will receive homework assignments to h elp them practice their English language skills. The 
homework handouts will be at the same frequency as the Healthy Mothers -Healthy Children Intervention  group 

Healthy Mothers -Healthy Children   Version 2  
Protocol   2019 -06-19 
 
NIH Behavioral and Social Intervention Clinical Trial Protocol Template v3.0 - 20180827  
  9 mothers. The equal attention control group children will receive 105 minutes of free play for 12  weekly classes 
and then 6 monthly free play classes.  
 
Participants will be tracked using ID numbers. All data will be double entered by different RAs into a  
SAS database with built -in range checks and skip patterns. Comparisons will be run on the two vers ions, and 
inconsistencies will be checked against the raw data and corrected. Data will be verified and stored in a secure 
server. Data will undergo range, consistency, and outlier che cks. All data decisions will be recorded in a 
logbook with an audit trai l. SAS datasets will be created for analysis.  
 
Risks to Human Subjects  
 
The intervention requires that during the Intensive Intervention ea ch intervention woman and child attend 12 
classes for 60 minutes. During Continued Support women and children will me et monthly for 6 months with 
their interventionists. The interventionist will weigh all wome n in a private area and provide feedback. The 
interventionist will then meet with the women for 60 m inutes to discuss nutrition and exercise challenges. The 
women w ill then attend a 45 minute exercise session. The women will also be encouraged to exercise 30 to 60 
minutes a day on most days of the we ek. The equal attention control group women and children will receive an 
equal number of days a nd minutes to meet, howe ver the mothers will receive English as Second Language 
classes and the children will receive free play.  
 
As a part of the first data collection after the mothers consent for themselves and their child, the mothers will fill 
out data. A health history and sports physical will be cond ucted on all mothers during the baseline data 
collection to ensure there are no medical problems before eng aging in physical activity. The mothers will also 
fill out a health history for their child. The sports physical w ill be conducted by a bilingual nurse practitioner 
hired for the study with experience in conducting sports physicals and medical clearance in a private room. At 
the data collection, the women will have their heigh t, weight, waist circumference, triceps an d subscapular 
skinfolds measured by a bilingual research assistant i n a private room. Children will have their height, weight, 
waist circumference, triceps and subscapular skinf olds measured by a bilingual research assistant in a private 
room with their mo ther present. We ar e aware that adverse events may occur and an adverse event monitoring 
committee will monitor their occurre nce and the overall risk of the study to both mother s and their children.  
Women who express fatigue durin g sessions will be excused  from the session and another time convenient for 
them will be scheduled to make up the content. If a woman expresses fatigue during data collection, the data 
collection session will b e terminated immediately, and a follow -up appointment scheduled. No adul ts 
expressed fatigue in Dr. Santos ’s previous studies. It is not anticipated that the classes or data collection will 
cause any adverse ef fects, but participants will be encouraged to identify any concerns to the study staff.  
Identifying data will be kept s eparate from questionnaires and locked in the PI’ s filing cabinets and locked 
office. All adult and child participants will continue to receive routine medical care from their health care 
providers throughout the study. Referral to their health ca re provid er will be made if any adverse effects are 
self-identified There are no known social or legal risks for the women who consent to participate for themselves 
and consent for their children in this study.  
 
Adequacy of Protection a gainst Risks  
 
We will hire on ly bilingual staff, and all recruitment and intervention materials and instruments will be in  
Spanish. Two months before enrollment, the bilingual project manager will give a prese ntation to staff at both 
public health departments and place Spanish languag e posters and brochures in each waiting room.  
The posters and brochures will describe the benefits of good nutrition and physical activity and state the 
eligibility criteria for study participation. We will also put ads in local Spanish language newspapers  and 
announcements on the local Spanish language radio station with our toll free number. Bilingual RAs will be  
available in the waiting rooms on clinic days to share information about the  study with mothers of Hispanic 
heritage. Face -to-face information classes worked well in our feasibility and  pilot studies and we were able to 

Healthy Mothers -Healthy Children   Version 2  
Protocol   2019 -06-19 
 
NIH Behavioral and Social Intervention Clinical Trial Protocol Template v3.0 - 20180827  
  10 enroll a sufficient number of participants each week. If mothers are int erested, the RAs will privately record 
their name and telephone number and schedule them for an  enrollment screening telephone call.  
We plan to enroll 10 mother -child dyads per week. However, we have built in to the timeline additional time for 
enrollment for each cohort if needed. If we have any difficulty enrolling participants, we will work with both 
health departments and El Centro Hispano to provide advice and assistance. We will also seek t he assistance 
of our Community Advisory Board, which will be made up of mothers of Hispanic heritage with a  
3-5-year-old child.  
 
The bilingual project manager will conduct a private telephone screening and ask mothers’  height and weight 
and their child’s gender, birthdate, height, and weight, ca lculate  BMI for mothers and BMI percentile for 
children and ask the questions on The Short Acculturation Sc ale for Hispanics [52]. If both mother and child 
meet the study criteria, an appointment will be made to meet at  the community center to confirm eligibility ; the 
bilingual RAs will measure height and weight and con firm BMI and BMI percentile. If eligible, the RA will 
explain, in Spanish, the study, requirements of participa nts, and the risks and benefits of particip ating, and 
random assignment; and all questi ons will be answe red. Only the mother and one 3 -5 year-old child will be 
eligible to join the study. Childcare will be availabl e for other children the mother brings with her in addition to 
her 3 -5-year-old child. Data collection with mothe r-child dyads wi ll occur in the morning or early afternoon 
when the mother’s older children will b e in school. Physiological data collection will be done in a private room. 
Bilingual RAs will collect the following data in the same order: health history questionnaire, spor ts physical, 
height, weight, waist circumf erence, triceps and subscapular skinfolds. The mothers will fill out their 
questionnaires in a group with a  bilingual RA who will read all questionnaires in Spanish. Data collection will 
take 75 minutes for each m other-child dyad. We have extra time in the schedule for make -up data collection  
At the time of data collection, women will have clinical data collected and  will be asked to fill out data forms. A 
sports physical will be conducted on all mothers during the baseline data collection to ensure there are no 
medical problems before engaging in physical activity. The sports physical will be conducted by a bilingual 
nurse practitioner hired for the study with experience in conducti ng sports physicals and medical clearance in a 
private room. The clinical measurements and data for ms should take approximately 75 minutes to complete.  
Women will be encouraged to self -identify any concerns  to the study staff. There will be adequate time for 
women to ask questions, and the y will be given ph one numbers to reach the PI and project manager if they 
have any further questions or concerns  
 
Confidentiality will be protected through a coding mechanism. The names of all participants will be removed 
from the data and a code number as signed. Each participant’s ide ntifying data will be separated from the study 
data, and the key identifying code numbers and the participant’s  identification will be kept by the PIs in a 
locked file cabinet in a locked office that only the PI and the p rojec t manager will have access to. Data will be 
reported in aggregate form without identifying information by s ite or individual. All research study personnel will 
be trained in IRB and HIPAA guidelines to maintain the security and confidentiality of the data.  Mothers will be 
made aware of the precautions that the research team will take in keeping their data confidential. All identifying 
information will be destroyed at the e arliest possible time following completion of the study. Publications arising 
from the  study will not contain  personal information. All data will be analyzed by groups, with no potential for 
individual participants to be identified.  
 
 
 
 
 
 
2.3.2  KNOWN POTENTIAL BENEFITS  
 
Potential Benefits of the Proposed Research to Human Subjects and Others  

Healthy Mothers -Healthy Children   Version 2  
Protocol   2019 -06-19 
 
NIH Behavioral and Social Intervention Clinical Trial Protocol Template v3.0 - 20180827  
  11  
The major potential benefit of this study is the provision of new knowledge about ways to improve outcomes for 
women of Hispanic heritage with limited English proficiency and their 4 -year old children. The intervention 
women will receive valuable i nformation about nutrition and physical activity education, coping skills training, 
and physical activity. Their 4 -year old children will receive valuable nutrition information and have an 
opportunity for physical activity. The equal attention control grou p will receive English as Second  
Language classes and the equal attention control group children will receive free play while their mothers are 
in class. Collection of data on mother’s weight, adiposity, health behavior, and self -efficacy and children’s 
weight and adiposity outcomes should provide information for women to share with their health care providers 
regarding efforts they are making to improve health behaviors in themselves and with their children.  
 
2.3.3  ASSESSMENT OF POTENTIAL RISKS AND BENEFITS  
 
See 2.3.1 above for assessment of potential risks and benefits  
3 OBJECTIVES AND ENDPOINTS   
  
Aim 1:  Test the efficacy of the intervention in slowing adiposity and weight  gain trajectory and improving health 
behaviors (nutrition and physical activity) in 3-5-year-old Hispanic children from Time 1 (0 months [baseline]) to 
Time 2 (9 months [completion of the intervention]) and Time 1 to Time 3 (15 months [after 6 months with  no 
contact from the study staff]).  
Aim 2:  Test the efficacy of the intervention  in decreasing adiposity and  weight and improving health behaviors 
and self -efficacy in overweight or obese Hispanic mothers from Time 1 to Time 2 and from Time 1 to Time 3.  
Primary outcomes  include slowing of c hild adiposity ( waist circumference and triceps and subscapular 
skinfol ds) and weight gain ( BMI percentile) trajectory and a decrease in mother’s adiposity and weight (BMI). 
We hypothesize  that intervention group childr en will slow the trajectory of adiposity and weight gain and 
intervention group mothers will decrease adiposity and weight significantly more than the control group.  
Secondary outcomes  include c hild and mothers health behaviors (nutrition and physical activity) and mother’s 
self-efficacy (nutrition and physical activity). We hypothesize  that intervention group children and mothers will 
improve health behaviors and mothers will improve self -efficacy significantly more than the cont rol group.  
Aim 3:  Identify the media tors through which the intervention influence s the trajectory of adiposity  and weight 
gain in children  and decrease in adiposity and weight in mothers. We hypothesize that h ealth behaviors and 
self-efficacy may mediate a diposity and weight loss in mothers and nutrition and physical activity behaviors in 
children may  mediate  a slower adiposity and weight gain trajectory.   
Aim 4:  Calculate the cost of implementing the interventi on for public health departments  and the costs  for 
mothers participating, from Time 1  to Time 2 and compare these costs to the outcomes of the intervention 
(cost -effectiveness) and the potential economic benefits of these outcomes (cost -benefit analysis) . We 
hypothesize  that the intervention is primarily focused on knowledge and behaviors in an at -risk population and 
may be cost -effective in comparison wi th other approaches to managing overweight and obesity.  

Healthy Mothers -Healthy Children   Version 2  
Protocol   2019 -06-19 
 
NIH Behavioral and Social Intervention Clinical Trial Protocol Template v3.0 - 20180827  
  12 Exploratory Aim: Determine whether intervention group mothers  in the overweight versu s obese BMI 
category benefit equally from t he intervention in adiposity, weight, health behaviors, and self -efficacy.     
4 STUDY DESIGN  
4.1 OVERALL  DESIGN  
This study wi ll use a two -group, randomized repeated measures study design to evaluate the efficacy of the 
intervention with 294 dyads of overweight or obese Hispanic mothers and their 3-5-year-old children. The 
mothers in the Healthy Mothers -Healthy Children Intervention  group will receive a 12 wee k intensive 
intervention and 6 months of continued support. The intensive intervention will include 60 minutes of nutrition 
and exercise education and coping skills training and a 45 minute physical activity class and a home -based 
physical activity program  handout each week f or 12 weeks . The continued support classes for the mothers in 
the intervention group will include 60 minutes of classroom discussion regarding problems they are having with 
nutrition and physical activity for themselves and their childr en and a 45 minute physical activity class monthly 
for 6 months. The children in the intervention group will receive an intensive intervention (105 minutes total), 
which will include 60 minutes of Color Me Healthy classes [26] and 45 minutes of free play weekly for 12 
weeks. The continued support classes for the intervention children will include a review of the Color Me 
Healthy classes [26] and 45 minutes of free play monthly for 6 months. Each weekly or monthly class for 
mothers and children is a total of 105 minutes. The equal attention control group mothers will receive English 
as a Second Language (ESL) classes for 105 minutes for 12 weekly classes and then monthly classes for 6 
more months. The equal attention control group mothers will receive homework assignments to help them 
practice their English language skills. The homework handouts will be at the same frequency as the Healthy 
Mothers -Healthy Children Intervention  group mothers. The equal attenti on control group children will receive 
105 minutes of free play for 12 weekly classes and then 6 monthly free play classes.   
Data will be collected at Time 1 (0 months [baseline]), Time 2 (9 months [completion of the intervention]) and 
Time 3 (15 months [after 6 months with no contact from the study staff]). Time 2 data will determine the 
magnitude of the intervention eff ects after the intensive interven tion and continued s upport; Time 3 data 
collection will test efficacy after the mother -child dyads have had sufficient time to implement their new 
nutrition, physical activity, and coping skills  on their own . These times were chosen because 3 to 6 months 
after completion of an intervention represents a standard length of time for follow -up in weight reduction 
studies, and gives mothers and children the time necessary to make changes in health behaviors [19]. 
4.2 SCIENTIFIC R ATIONALE FOR STUDY DESIGN  
The study design will use a two -group randomized repeated measures study design to evaluate the efficacy of 
the intervention with 294 dyads of overweight or obese Hispanic mother s and their 3 -5 year old children.  
4.3 JUSTIFICATION FOR INTERVENTION  
The intervention was pilot tested face -to-face in this population and was found to be feasible and acceptable.  
4.4 END-OF-STUDY DEFINITION  
 

Healthy Mothers -Healthy Children   Version 2  
Protocol   2019 -06-19 
 
NIH Behavioral and Social Intervention Clinical Trial Protocol Template v3.0 - 20180827  
  13 A participant is considered to ha ve completed the study if she and her child has completed Time 1 (baseline), 
Time 2 (9 months) and Time 3 (15 months) data collection.  
5 STUDY POPULATION  
 
Settings.  The study will build upon established partnerships between The University of North Carolina at 
Chapel Hill, the Chatham County Health Department and Durham County Health Department. Bilingual 
research assistants (RAs) will distribute brochures, give mothers information about the study, answer 
questions and enroll mother -child dyads. This approach  worked well in previous studies [32, 33]. In 2015, the 
Chatham County Health Department provided 82,314 medical visits and 42% (34,572) were provided to 
Hispanic adult s and children and the Durham County Health Department provided 78,123 visits and 46% 
(35,936) were provided to Hispanic adults and children. In 2015, the Durham County Health Department had 
650 Hispanic mother and 4 -year old child dyads and the Chatham Co unty Health Department had 800 
Hispanic mother and 4 -year old child dyads (Total = 1,450; Mean = 725). A total of 78% of Hispanic mothers 
are overweight or obese [34]. Thus it is anticipated that approximately 78% of the mothers at both sites will 
meet inclusion criteria (n = 1,131), and 50% (n = 565) will agree to participate with their 4 -year-old child. Of 
those who agree to participate (n = 565), approximately 70% (n = 396) will score a 1.00 -2.99 on the Short 
Acculturation Questionnaire for Hispanics establishing low acculturation [35]. These numbers are adequate to 
meet our projected enrollment of 294 dyads. Specifically, we will enroll 36 -38 dyads for each cohort in each 
site in each of eight rolling enrollment periods. W e will rent space for the intervention from community centers 
in Chatham and Durham Counties as we have done in previous studies (see Letters of Support). The public 
health departments and community centers are situated in the communities where participant s live and they 
are either within walking distance from their homes or on bus lines, increasing the probability of successful 
recruitment and retention for the proposed study. In previous studies, the mothers drove to the community 
centers together [23]. The centers have classrooms and playgrounds.  
 
Sample.  Inclusion criteria for mothers will be age 18 years or older; self -identification as Hispanic; limited English 
proficiency; l ittle acculturation, as measured by the Short Acculturation Scale for Hispanics [35] with a score from 
1.00 to 2.99; ability to understand spoken Spanish; a BMI >25kg/m2; residence with the child; consent to join the 
study and  consent for their child to join the study. Inclusion crite ria for children will be age 3 -5-years; ability to 
understand spoken Spanish; and a BMI > 25th percentile for age and gender. Health care providers will not be 
asked to give permission for mother -child dyads to join the study. Mothers will fill out a health history 
questionnaire to ascertain if they have a heart murmur, congenital heart disease, family history of sudden death, 
difficulty exercising or psychological problems that would prevent partic ipation. A sports physical will be 
conducted by a bilingual nurse practitioner on all mothers during baseline data collection to ensure that they 
have no medical problems. If a mother answers yes to any of these health history questions or the nurse 
practi tioner finds a heart murmur or any other concerns, she will be excluded from the study and referred to a 
health care provider. Dyads will be enrolled in eight cohorts over four years. Each cohort will be enrolled over a 
1-month period.  
5.1 INCLUSION CRITERIA  
 
Inclusion criteria for mothers will be age 18 years or older; self -identification as Hispanic; limited English 
proficiency; little acculturation, as measured by the Short Acculturation Scale for Hispanics [35] with a score 
from 1.00 to 2.99; ability to understand spoken Spanish; a BMI >25kg/m2; residence with the child; consent to 
join the study and consent for their child to join the study. Inclusion crite ria for children will be age 3 -5-years; 
ability to understand spoken Spanish; and a BMI > 25th percentile for age and gender.  
5.2 EXCLUSION CRITERI A 

Healthy Mothers -Healthy Children   Version 2  
Protocol   2019 -06-19 
 
NIH Behavioral and Social Intervention Clinical Trial Protocol Template v3.0 - 20180827  
  14 Health care providers will not be asked to give permission for mother -child dyads to join the study. Mothers will 
fill out a health history questionnaire to ascertain if they have a heart murmur, congenital heart disease, family 
history of sudden death, difficulty exercising or psychological problems that would prevent participation. A sports 
physical will be conducted by a bilingual nurse practitioner on all mothers during baseline data collection to 
ensure that they have no medical problems. If a  mother answers yes to any of these health history questions or 
the nurse practitioner finds a heart murmur or any other concerns, she will be excluded from the study and 
referred to a health care provider.  
5.3 LIFESTYLE CONSIDERATIONS  
N/A 
5.4 SCREEN FAILURES  
 
Screen failures will not be consented or enrolled in the study. We will keep track of screen failures and reasons 
why they failed to meet inclusion criteria.  
5.5 STRATEGIES FOR RECRUITMENT AND RETENTION  
 
Proce dures for Minority Recruitment and Enrol lment and Challenges  
 
We will hire only bilingual staff, and all recruitment and intervention materials and instruments will be in 
Spanish.  Two months before enrollment , the bilingual project manager  will give a presentation to staff at both  
public health departments and place Spanish language posters and brochures in each waiting room. The 
posters and brochures will describe  the benefits of good nutrition and physical activity  and state the eligibility 
criteria for study participation. We wi ll also put ads in local Spanish language newspapers and announcements 
on the local Spanish language radio station with our toll free number. Bilingual RAs will be available in the 
waiting rooms on clinic days to share information about th e study with Hisp anic mothers . Face -to-face 
information classes  worked well in our feasibility and pilot studies and we were able to enroll  a sufficient 
number of participants each week  [23]. If mothers are interested, the RAs will privately record their name and 
telephone number an d schedule them for an enrollment screening telephone call . This technique also worked 
well in our pilot study, wh ich included mother -child dyads  with limited English p roficiency [23]. Of 82 mother -
child dyads approached in the pilot, 68% ( n = 56) consented to participate  over 1 month [23].  We plan to enroll 
approximately 10  mother-child dyads  per week. However, we have built into the t imeline additional time for 
enrollment  for each cohort if needed . If we have any difficulty enrolling participants, we will work with both 
health departments to seek advice on how to improve enrollment in the study.  
 
The bilingual project manager will conduct a private telephone screening and ask mothers’ height and weig ht 
and their child’s gender, birthdate , height, a nd weight, calculate BMI for mothers and BMI percentile for 
children and ask the questions on The Short Acculturation Scale for Hispanics [35]. If both mother and child 
meet the study criteria, an appointment will be made to meet at the community center to confirm eligibility; the 
bilingual RAs will measure height and weight and confirm  BMI and BMI percentile.  If eligible, the  RA will 
explain, in Spanish , the study, requirements of participants, and the risks and benefits of participating , and 
random assignment; and all questions will be answered . Only the mother and one 3-5-year-old child will be 
eligible to join the study. Childcare will be available for other children the mother brings with her in addition to 
her 3 -5-year-old child. Data collection with mother -child dyads  will occur in the morn ing or early afternoon  
when the mother’s older children will be in school. Physiological data collection will be done in a private room. 
Bilingual RAs will collect  the following data in the same order:  health history questionnaire, sports physical, 
height, weight, waist circumference, triceps and subscapular skinfolds. The mothers will fill out their 

Healthy Mothers -Healthy Children   Version 2  
Protocol   2019 -06-19 
 
NIH Behavioral and Social Intervention Clinical Trial Protocol Template v3.0 - 20180827  
  15 questionnaires in a group with a bilingual RA who will read all questionnaires in Spanish. Data collecti on will 
take 75 minutes for each mother -child dyad . We have extra time in the schedule for make -up data collection . 
 
Proce dures for Minority Retent ion and Challenges  
 
Weight management studies typically have attrition rates ranging from 10 %-30% [19]. To strengthen retention, 
our classes will be interactive, with culturally and linguistically tailored content developed  to engage and 
sustain  the interest  of the mother -child dyads.  Mothers who miss class will be offered a make -up class over the 
phone, and reminded when the next class will be held. Additional incentives will  include c hildcare for other 
children who accompany mothers and their 3-5-year-olds to cla ss and  recipe s and handouts in Spanish on 
how to improve their children’s  nutrition and physical activity behaviors . Mothers will be asked for telephone 
numbers of several family members and permission to call the m if we cannot reach the m. We will  be as fl exible 
as possible in scheduling enrollment  and data collection appointments and provide tokens of appreciation suc h 
as birthday cards and a quarterly  newsletter with updates on the study. Mothers in both groups will receive $25  
after each data collection. These approaches proved successful in our pilo t study with Hispanic mothers with 
limited English proficiency, where attrition was only 9% -15% [23] and those mothers  who stopped coming had 
moved out of the state. We will make every effort to keep our attrition rate lower than the projected 15%. If 
retention rates drop below 85%, we will contact the mothers to ask why they stopped coming and develop 
strategies to  meet the needs of each mother to  assist them to continue in the study if possible.  
6 STUDY INTERVENTION(S) OR EXPERIMENTAL MANIPULATION(S)  
6.1 STUDY INTERVENTION (S) OR EXPERIMENTAL MANIPULATION(S)  ADMINISTRATION .   
 
6.1.1  STUDY INTERVENTION  OR EXPERIMENTAL MANIPULATION  DESCRIPTION  
Intensive Intervention for Mothers  
The intensive intervention classes are based on the classes from our Family Partners for Health study, 
adapted for Hispanic mothers with limited English proficie ncy and their 3 -5-year-old children [23, 36, 37]. 
Classes will be run by a bilingual interventionist and will be 60 minutes long with 1 8-19 mothers. We chose 18 -
19 mothers since the enrollment is rolling and these mothers will be enrolled together and this cohort approach 
worked well in our previous studies [23, 37]. Classes will include nutrition and physical activity education and 
coping skills training using problem solving, assertiveness training, cognitive restructuring, and conflict 
resolution around problems of nutrition and physical activity for mothers and t heir children. The nutrition 
classes will include content on understanding calories, protein, carbohydrates and fat, making healthy 
substitutes that are culturally acceptable, choosing healthy foods when eating out at a favorite fast food 
restaurant, using  actual menus, and understanding how portion control can make a difference for them and 
their children using food models and food labels in Spanish. Mothers will receive information on how to shop as 
economically as possible and how to shop at local farmer s’ markets, which are geographically close to the 
mother’s homes, where they may have better access to fresh fruits and vegetables. At the end of each class, 
mothers will be asked to set a nutrition or physical activity goal for the coming week for themsel ves and their 4 -
year-old child.  
 
Physical activity classes will be held for 45 minutes after the intensive intervention classes and will include a 
warm -up and then activities such as Zumba, Kick Boxing, walking, use of light weights and stretch bands, and  
a cool -down. The bilingual interventionist will reinforce the importance of physical activity and ways to increase 
physical activity for mothers and their children. The importance of decreasing sedentary behaviors for mothers 
and children will be reinforc ed in all classes. During the first week, each mother will receive a pedometer and 
log book for self -feedback.  Mothers will be encouraged to bring their pedometer log book in weekly for the 

Healthy Mothers -Healthy Children   Version 2  
Protocol   2019 -06-19 
 
NIH Behavioral and Social Intervention Clinical Trial Protocol Template v3.0 - 20180827  
  16 bilingual interventionist to review. Pedometers will be used as a part of the intervention instead of a Fitbit 
because some of the women may not have a computer in their home to upload their data. Mothers will be 
encouraged to increase their physical activity weekly by small increments until they are physically active 30  to 
60 minutes a day on mo st days of the week with their 3 -5-year old child. Missed physical activity classes will 
not be made up. Mothers in the intervention group will be encouraged to develop their own home -based 
physical activity program using suggesti ons given in the physical activity class and a home -based physical 
activity handout in Spanish given after each physical activity class ti increase their and their child’s physical 
activity. The handouts will be reviewed with the mothers and physical activ ities demonstrated by the bilingual 
interventionist.  
 
Intensive Intervention for Children  
 
The children’s classes will include a 60 minute session plus 45 minutes of supervised free play with 18 -19 
children at the same time their mothers are in class. Eac h class will have 1 teacher and 3 teacher assistants to 
ensure safety. The Color Me Healthy [26] curriculum, which consists of 12 classes in Spanish, was purchased 
and used for the pilot study [23]. All of the classes are at a 3 -5-year-old devel opmental level and include a CD 
with music and a song about the class of the week, colorful picture cards, and opportunities for the children to 
try new fruits and vegetables. Each week the bilingual interventionist will give mothers a Color Me Healthy [26] 
handout in Spanish that includes strategies for feeding their children healthier meals and snacks and 
increasing their daily physical activity. While their mothers are in physical activity class, the children will have  
45 minutes  of physical activity (supervised free play) in a playground at the community center or dance and 
actively play with the bilingual interventionist if it is raining.  
 
Continued Support  for Mothers and Children  
 
During continued support, intervention mother -child dyads will return to the community center for classes once 
a month for 6 months. The mothers will receive a calendar at the completion of the intensive intervention 
classes with the dates and times and a reminder phone call several days before each class. As a part of the 
intervention, mothers will be weighed and then have the opportunity to engage in a discussion run by the 
bilingual interventionist, who will help mothers solve problems they have encounte red related to nutrition and 
physical activity for themselves and their children for 60 minutes and then receive a 45 minute physical activity 
class. The children will meet with a bilingual interventionist to review a class from the Color Me Healthy  [26] 
curriculum for 60 minutes and then receive 45 minutes of free play. If a mother and child miss a class, the 
bilingual interventionist will call and ask how the mother and child are doing and give the date of the next class. 
Continu ed support classes will not be made up.  
 
Equal Attention Control Group  
 
Mothers  in the control group will receive English as a Second Language (ESL) classes taught by professional 
ESL teachers; they will receive the same number of contacts and time as the intervention group mothers (105 
minutes weekly for 12 weeks and 105 minutes mon thly for 6 months). The ESL classes will be offered because 
when exit interviews were conducted after the pilot study [23], mothers were asked if they “were not in the 
intervention  group, what type of classes would they want?” The mothers (90%) wanted ESL classes to improve 
their English. Providing these classes to the control group most likely will improve enrollment and retention. 
Children in the control group will have free play while their mothers are in class and will receive the same number 
of contacts and times as the children in the intervention group (105 minutes weekly for 12 weeks and 105 minutes 
monthly for 6 months). The control classes will be held on separate days of t he week from the intervention 
classes in the same community centers. Data will be collected from the mother -child dyads in the control group 
at Time 1, Time 2, and Time 3; and the mothers will receive $50 each time. Mothers will be called several days 
before classes and data collection to remind them. Mothers will receive a pedometer and log book after they 

Healthy Mothers -Healthy Children   Version 2  
Protocol   2019 -06-19 
 
NIH Behavioral and Social Intervention Clinical Trial Protocol Template v3.0 - 20180827  
  17 have completed Time 3 data. Attrition rates in our previous studies were equal in the intervention and control 
groups and ranged from 9% to 15% [23]. 
6.1.2  ADMINISTRATION  AND/OR DOSING  
 
See 6.1.1  for detail s 
 
6.2 FIDELITY  
 
6.2.1  INTERVENTIONIST TRAINING  AND TRACKING  
 
Fidelity of the Intervention  
 
We have structured the fidelity of the intervention using the NIH five category Treatment Fidelity Framework 
[38]. For category one, treatment design , both the intervention and control condition will receive different 
content but will be the same length, number, and duration of contact over time. The bilingual interventionists 
will have experience teaching health interventions, and the theoretical model is clearly articulated. For category 
two, training , the bilingual interventionists  will be trained by the PI and teach back the interven tion to the PI. 
For category three, delivery of the intervention , integrity will be assessed by observation of two randomly 
selected classes per month by the project manager who will use a checklist to score classes based on pre -
identified content, and drift will be defined as teaching less than 80% of protocol content. If drift occurs, the 
bilingual interventionists  will be retrained until the pro tocol is followed consistently. W e will also  use a list of 
behavioral indicators to assess the interventionists ’ skills in facilitating classes, engaging mother -child dyads, 
role playing, problem solving, providing positive feedback, and goal setting. Retraining will be prov ided if 
proble ms are found. In our pilot study  [23], we had little difficulty in maintaining consistency of the intervention. 
The bilingual interventionists  will collect data on attendance at e ach class, reasons for non -attendance, and 
make -up classes  provided. Category four, receipt of treatment , will be evaluated during the class by the 
bilingual interventionist who will assess understanding and answer all questions. Category five, enactment o f 
intervention skills , will be evaluated during the six monthly continued support classes by the bilingual 
interventionist.  
6.3 MEASURES TO MINIMIZE BIAS : RANDOMIZATION  AND BLINDING  
 
After enrollment and baseline assessment, dyads  will be randomized to either the intervention or control group 
using a computer -generated randomization table , stratifying by BMI group, overweight (25 – 29.9 kg/m2) and 
obese ( >30 kg/m2), and utilizing blocking to help ensure balance between the groups . Mothers w ill be informed 
of their group assignment by telephone. We have not included fathers, as in previous studies in this population, 
because the majority of fathers work 6 days a week and cannot attend class [7, 23]. Data collection research 
assistants will be blinded to group status.  
6.4 STUDY INTERVENTION /EXPERIMENTAL MANIPULATION  ADHERENCE  
 
See 6.2.1 for details  
6.5 CONCOMITANT THERAPY  
 

Healthy Mothers -Healthy Children   Version 2  
Protocol   2019 -06-19 
 
NIH Behavioral and Social Intervention Clinical Trial Protocol Template v3.0 - 20180827  
  18 N/A 
 
6.5.1  RESCUE THERAPY  
 
N/A 
 
7 STUDY INTERVENTION /EXPERIMENTAL MANIPULATION  DISCONTINUATION  AND PARTICIPANT  
DISCONTINUATION /WITHDRAWAL  
 
7.1 DISCONTINUATION  OF STUDY INTERVENTION /EXPERIMENTAL MANIPULATION  
 
The intervention will only be discontinued after consultation with the study team and the program officer .  
7.2 PARTICIPANT  DISCONTINUATION /WITHDRAWAL FROM THE STUDY  
 
Participants are free to withdraw from participation in the  study at any time upon request . 
 
An investigator may discontinue a participa nt from  the study for lost-to-follow up  and unable to contact subject . 
 
The reason for participant discontinuation or withdrawal from th e study will be recorded.  Subjects who sign the 
informed consent form and are randomized but do not receive the study intervention may be replaced.  
Subjects who sign the informed consent form, and are randomized and receive the study intervention , and 
subsequently withdraw, or are  discontinued from the study will not be replaced.  
7.3 LOST TO FOLLOW -UP 
 
A participant will be consid ered lost to follow -up if she fails to return for scheduled visits and study staff are 
unable to contact the participant after at least 3 attempts .  
 
The following actions must be taken if a participan t fails to return for a required study visit:  
 
The site will attempt to contact the participant , reschedule the missed visit , counsel the participant on the 
importance of maintaining the assigned visit schedule and ascertain if the participant wishes to and/or should 
continue in the study . 
 
Before a participant is deemed lost to follow -up, the investigator or designee will make every effort to regain 
contact with the participant (where p ossible, 3 telephone calls. These contact attempts will be documented in 
the participant’s medical record or study file.  
 
Should the participant  continue to be unreachable, he or she will be considered to have withdrawn from the 
study with a primary reason o f lost to follow -up. 
 
 
8 STUDY ASSESSMENTS AND PROCEDURES  

Healthy Mothers -Healthy Children   Version 2  
Protocol   2019 -06-19 
 
NIH Behavioral and Social Intervention Clinical Trial Protocol Template v3.0 - 20180827  
  19 8.1 ENDPOINT AND OTHER NON -SAFETY ASSESSMENTS  
 
Variables and Their Measurement  Respondent  Time 1  Time 2  Time 3  
Short Acculturation Questionnaire for Hispanics  Mother  X   
Health History Questionnaire  Mother  X   
Sports Physical  Mother  X   
Adiposity (Primary Outcomes)      
   Waist Circumference  Mother/Child  X X X 
   Triceps and Subscapular Skinfolds  Mother/Child  X X X 
Weight Status (Primary Outcomes)      
   Height/Weight  Mother/Child  X X X 
   BMI/BMI Percentile  Mother/Child  X X X 
Health Behavior      
   Adult Health Behavior Survey  Mother  X X X 
   Health Promoting Lifestyle Profile II  Mother  X X X 
   24-hour Food Recall for 3 days  Mother for Self/Child  X X X 
   Accelerometer for 7 days  Mother for Self/Child  X X X 
Self-Efficacy      
   Eating Self -Efficacy Scale  Mother  X X X 
   Exercise Self -Efficacy Scale  Mother  X X X 
Demographic Data  Mother for Self/Child  X   
Health History Update Questionnaire  Mother for Self/ Child   X X 
Process Evaluation Bi -Monthly  Project Manager     
Exit Interviews  Mother    X 
Time 1 (0 months [baseline] ); Time 2 (9 months [completion of th e intervention]); Time 3 (15 months [after 6 months with no contact from the study 
staff]).  
 
8.2 SAFETY ASSESSMENTS  
 
N/A 
8.3 ADVERSE EVENTS AND S ERIOUS ADVERSE EVENTS  
 
8.3.1  DEFINITION OF ADVERSE EVENTS  
See Data Safety Monitoring ( DSMP ) Below  
 
8.3.2  DEFINITION OF SERIOUS ADVERSE EVENTS  
See DSMP Below  
 
8.3.3  CLASSIFICATION OF AN ADVERSE E VENT  
See DSMP Below  
 
8.3.3.1  SEVERITY OF EVENT  
See DSMP Below  
 
 
8.3.3.2  RELATIONSHIP TO STUDY INTERVENTION /EXPERIMENTAL MANIPULATION  
 
 
 
 

Healthy Mothers -Healthy Children   Version 2  
Protocol   2019 -06-19 
 
NIH Behavioral and Social Intervention Clinical Trial Protocol Template v3.0 - 20180827  
  20 
 
Data and Safet y Monitoring Plan 
 
Study Identification  
 
NIH Study  Number  – 1R01NR017199 -01 
 
Study  Title – Healthy Mothers: Healthy Children: An Intervention with Hispanic Mothers and their Young 
Children  
 
Principal  Inves tigator  – Hudson Santos , PhD, RN 
Study Overvi ew 
The overall goal of this project is to determine whether a nutrition and physical activity education, coping skills 
training, exercise program, and a home -based exercise program will decrease adiposity  and weight, and 
improve health behaviors and self -efficacy in mothers  of Hispanic heritage and slow excessive adiposity and 
weight gain in their 4 -year old children.  The DSMP  outlined below  for the proposed study will  adhere  to the 
protocol  approved by The Univers ity of North  Carolina  at Chapel  Hill (UNC -CH) Institutional Review Board  (IRB) 
and the National Institutes of Health  (NIH)  and the National Institute of Nursing Research  (NINR) .  
  
SECTION A. Monitoring Entity  
 
Considering the study rationale, population, procedures, and the risk: benefit profile as outlined, the overall risk 
level for participation in this study is classifi ed as no more than minimum risk.  
 
1)  Individual Roles and Responsibilities  
 
An Exec utive Committee  will be formed  to oversee the conduct of the study.  The committee  will be comprised  of 
nine members:  Dr. Santos  (Principal Investigator [PI]) and the Study Investigators, Drs. Ammerman, Crandell, 
Evenson,  Faith, Peragallo -Montano, Perreira, Perrin, and Waters . The PI  will Chair the Committee,  which  will 
meet monthly  to review  the activities  of the  study  including  management,  personnel,  recruitment,  performance,  
and any emer ging problems.  
 
The Independent  Monitor  (ISM) for this study  will be  Dr. Mary  Lynn. Dr. Lynn  has been  the Inaugural Assist ant 
Director  for Operations  of the Office  of Human  Research  Ethics at UNC -CH, which was preceded  by six years  
as the IRB Chair  and Chair of the School of  Nursing  (SON)  IRB. Dr. Lynn  is not associated  with this research  
project  and thus works  independently  of the PI . Dr. Lynn  is not one of the key personnel involved  in this grant.  
She is qualifi ed to review  the participant  safety  data generated  by this study  because of  her unique expertise  in 
human research  ethics and serving  as the ISM on multiple  previous studies .  
 
B. Procedures for Safety, Risk, and Confidentiality  
 
1) Monitoring Study Safety  
 
From the initial screening of participant s by inclusion and exclusion criteria to the informed consent process to 
the provision of participant study instruction to staff training in Good Clinical Practices (GCP) and regulations 
pertaining to the Conduct of Human Participant Research to weekly cont act with participants to internal 
monthly quality control audits and protocol fidelity monitoring to the real -time review of adverse events (AE) 
and serious adverse events (SAEs) by the PI, Study Investigators and the ISM, the study will be carefully 
overs ighted.   
 

Healthy Mothers -Healthy Children   Version 2  
Protocol   2019 -06-19 
 
NIH Behavioral and Social Intervention Clinical Trial Protocol Template v3.0 - 20180827  
  21 Drs. Santos , Ammerman, Crandell (Study Statistician), Evenson, Faith , Lynn (ISM) Peragallo -Montano, Perreira, 
Perrin , and Waters will revi ew the data for this study quarterly . We will examine participant accrual and  
adherence to the protocol regarding demographics and inclusion and exclusion criteria, and compliance of 
treatment, AE and SAE rates quarterly, and report regarding statistical power implications of dropouts and 
missing data annually.  
 
Data  on compliance  to the intervention  will be collec ted weekly  by the Project Manager ( PM) and reviewed  
quarterly  by the S tudy Investigators,  Study S tatistician,  and the ISM. Compliance  on the part of participants  will 
be evaluated  by attendance  and process  evaluation  as outlined  in the study.  If intervention attendance  drops  
below 85%,  the mothers  who have  stopped  coming  will be called to ask for feedback.  Using information  gained  
from these  phone  interviews,  the PI  will schedule  a meeting  with the Study Investigators and the ISM to discuss  
methods  for improving  compliance.  
 
As in previous studies, the PI and the Study Statistician will oversight and train the PM to establish a system to 
ensure the verification of source data compliance. The source data will include original records necessary for 
the reconstruction and evaluatio n of the clinical trial. It will be clear who documented the data, documentation 
will be readable, signatures identifiable, contemporaneous, original copy, accurate and consistent, long -lasting 
and durable, available and accessible, complete, consistent, c redible, and corroborated. All data will be first 
checked by two separate Research Assistants (RAs) at different times. REDCap will be used as our Re search 
Electroni c Data Capture System. The PI  has been trained in REDCap and has u sed it in previous studie s and 
REDCap i s supported by UNC -CH. The REDCap database creation will be oversighted by Dr. Crandell ( Study 
Statistician). Dr. Crandell will run comparisons  and trained RAs  will compare against source data and make 
corrections as needed. A data log book w ill be created to establish an audit t rail for compliance as the PI  has 
done in previous studies .  
 
Drs. Santos , Ammerman, Crandell, Evenson, Faith, Peragallo -Montano, Perreira Perrin, and Waters  will 
personally conduct and supervise the study. We will regi ster the study in ClinicalTrials.gov. We will follow the 
protocol and ensure all study staff follow the protocol. All staff assisting with the study will be informed of their 
obligations. We will ensure informed consent, approval and reporting. We will rep ort to the NIH/NINR Program 
Officer, Dr. Mary Roary, any AEs or SAEs. We will maintain adequate records and make them available for 
inspection. We will ensure initial and continuing review by UNC -CH IRB and will report all changes to research 
and involving  risks to subjects, and not make any changes without IRB approval except where necessary to 
eliminate immediate hazards. All of the study team are CITI trained and follow the Good Clinical Practice (GCP) 
Guidelines.  
 
2)   Minimizing Research -Associated Risk  
 
Diligent study safety monitoring will be conduct ed by the PI  as follows. The PI will work with the IRB to set up a 
schedule of selected cases to ensure compliance with IRB requirements. The PI and Study Investigators have 
worked c losely with the IRB in previous studies providing the data requested for audits as required. Risks to 
human subjects will be minimized through the utilization of establish protocols that have worked well in 
previous studies. We are aware that AEs and SAEs may occur and an Adverse Event Monitoring C ommittee 
will monitor their occurrence and the overall risk of the study to both m others and their children.  
 
Mothers  who express fatigue during sessions will be excused from the session and another time convenient for 
them will be scheduled to  make up the content. If a mother  expresses fatigue during data collection, the data 
collection session will be terminated immedi ately, and a follow -up appointment scheduled. No mothers 
expressed fatigue in the PI ’s previous studies. It is not anticipated that the classes or data collection will cause 
any adverse effects, but participants will be encouraged to identify any concerns to the study staff. All mothers 
and their children  will continue to receive routine medical care from their health care providers throughout the 
study. Referral to their health care provider will be made if any adverse effects are self -identified There are  no 

Healthy Mothers -Healthy Children   Version 2  
Protocol   2019 -06-19 
 
NIH Behavioral and Social Intervention Clinical Trial Protocol Template v3.0 - 20180827  
  22 known soc ial or legal risks for the mothers  who consent to participate for themselves and consent for their 
children in this study.  There will be adequate time for mothers  to ask questions, and they will be given phone 
numbers to reach the PI and PM  if they have any further questions or concerns .  
 
Institution -Wide Assurances  will be assured by the use of the protocol, which will be conducted fully in 
keeping with the signed PI in accordance with UNC -CH IRB, NIH, and NINR.  
  
3)  Protecting Confidentiality of Participant data Participant Screening and Enrollment  
 
All data from participants screened for the study will be entered into  the REDCap  electronic study database. 
Designated research staff will collect, gather, and enter required data ( written informed consent, Health 
Insurance Portability and Accountability Act ( HIPAA ) authorization, medical history and demographics) onto 
study data forms. Screened patients who do not meet study eligibility will have specific screening data entered 
into the study database. The collected data will be helpful in examining the patient population and feasibility of 
enrollment criteria and will include gender, age, race and reason for exclusion. All dates will be shifted and 
other Personal Health Information (PHI) will be removed from the study database upon study completion. All 
data obtained from this study will be used for research purposes only and will comply with Federal HIPAA 
regulations.   
 
Written  informed consent  will be obtained from each  participant  at entry  into the study.  Informed  consent  is 
obtained  by the following  process. The  participant  will be read the study  consent  form in Spanish. The  bilingu al 
PM or trained  bilingual  RA will meet  with the participant to  review  the form,  to confirm  the participant’s  
understanding  of the study,  and to answer  any questions that  the participant  might  have. Once  the participant  
demonstrates  understanding  of the study  and agrees  to participate  in the study,  the consent  will be signed  in the 
presence  of the bilingual PM or bilingual  RA. The IRB will oversight yearly renewal of consent forms and the PI 
and the research team will provide data as requested for the renewal.  
 
Confidentiality will be protected through coding mechanism s. The names of all participants will be removed from 
the data and a code number assigned. Each participant’s identifying data will be separated from the study data, 
and the key identifying code numbers and the participant’s identi fication will be kept by the PI  in a password 
protected computer in a locked o ffice that only the PI and the PM  will have access to. Data will be reported in 
aggregate form without identifying information by site or individual. All research study personnel will be trained 
in IRB and HIPAA guidelines to maintain the security and confident iality of the data. Mothers will be made aware 
of the precautions that the research team will take in keeping their data confidential. All identifying information 
will be destroyed at the earliest possible time following completion of the study. Publicatio ns arising from the 
study will not contain personal information. All data will be analyzed by groups, with no potential for individual 
participants to be identified.  
 
Case Report Forms. All proposed study specific case report forms (source documents) for data collection will 
be desi gned by the PI and PM in concert with the Study Statistician  and transferred by the PM  into electronic 
Case Report Forms (eCRFs) for use in the study’s REDCap database. These study specific eCRFs source 
documents (study logs fo r correspondence, contacts , compensation and other forms such as pre -eligibility 
screens) will be coded by the  participant’s unique study identification number for all data collected including 
study instruments will be maintained in the par ticipant research record that will be made accessible to study 
monitors. Completed instruments that require a signature on a paper CRF will be scanned and uploaded into 
the study database as well as maintained on file in accordance with UNC -CH policies and a pplicable Federal 
Regulations for the Conduct of Human Participant Research.  
  
Binders. The PM will prepare and maintain a participant -specific binder for each participant containing all non -
eCRFs records. A regulatory file will also be maintained to inclu de the IRB approved Protocol, original 

Healthy Mothers -Healthy Children   Version 2  
Protocol   2019 -06-19 
 
NIH Behavioral and Social Intervention Clinical Trial Protocol Template v3.0 - 20180827  
  23 Informed Consent documents, HIPAA forms and other study -related regulatory documents. All paper research 
records and CRFs will be maintained in a locked file cabinet in a secure facili ty within the SON . Access to the 
research rec ords, study database and PHI  will be restricted to study  personnel as approved by the PI  and IRB. 
As w ith all studies conducted at the UNC -CH, this study is also el igible for a random audit by  Office of 
Compliance.   
 
Data Processing.  This study will use Research Electronic Data Capture (REDCap) for data capture and 
management.  
  
Data Security.  Ensuring data security, compliance with 21 CFR 11 and maintaining the integrity of PHI is a top 
priority.  
  
Data Entry.  Each participant will b e assigned a unique study identifier, all PHIs will be masked, and data 
exports will be limited to the PI, the P M, and Study Statistician  for generating reports and the conduct of 
statistical data analysis.  
  
Data Monitoring.  Ongoing quality control procedures will be implemented for data collection , storage and 
processing. The PM  will conduct monthly monitoring of the study database and generate a report for the PI  to 
review at team meetings. Standing agenda items for these meetings will include part icipant recruitment and 
retention, AEs, SAEs, protocol deviations, data integrity and overall study conduct.  
  
Database  Protection . The REDCap database  will be  secured  with password  protection.  The informatics  
manag er receives  only coded  information,  which  is enter ed into the database  under those  identification  
numbers. Electronic  communication  with outside  collabor ators involves  only unidentifiable  information.  
 
SECTION C.  Procedures for Identifying, Reviewing and Reporting Adverse Events  
 
1)  Identifying.  Potential risks identified for participants are outlined in the Protection of Human Participants 
and will also be outlined in the IRB  approved informed consent document.  
 
Dr. Mary  Lynn (Chairperson  of UNC -CH School  of Nursing  Human  Particip ant Resea rch Review  Committee  
and ISM ) will chair  the Adverse  Event Monitoring  Committee,  which  will include  Drs. Santos  (PI), Ammerman, 
Crandell (Study Statistician), Evenson, Faith , Peragallo -Montano, Perreira, Perrin , and Waters  and the PM. The 
committee  will meet  every  3 months  or more  often  as warranted,  to review  data related  to AEs and SAEs and 
assu re that safety  standards  are maintained.  Despite  usual precautions,  we are aware  that AEs and SAEs may 
occur,  and this committee will monitor  their occurrence  and the  overall  risk of the study to both mothers  and 
their children.  We will develop  a system to test whether abnormalities  are equal ly distributed  between  the 
intervention and  equal attention  control groups.  Data will be presented  to the committee  if a significant incre ase 
in abnormalities  is noted. The committee  will be asked  to establish  measurable  standards  that must  be met 
before they recommend  modificati on of the study  on the basis  of safety.  These  stand ards will be clearly  
delineated  in the meeting minutes  and approved  by the comm ittee. The committee  will provide  the PI with 
recommendatio ns regarding problems  that would  require  modification for safety  reasons.  Minutes  of each  
meeting will  be kept,  and all actions and decisions documented  to establish  an audit  trail. Dr. Crandell,  the 
Study S tatistician , will be instruct ed by the PI to prepare  the randomization  plan for the  study  and prepare  
reports  for the committee  under  the direction  of Dr. Lynn  (Chair  and ISM ). 
 
2)  Reviewing.  Adverse events wil l be assessed and graded as follows.  
 
Expected/Anticipated —Identified in nature, severity, or frequency in the current protocol, informed consent, 
investigator brochure, or with other current risk information.  

Healthy Mothers -Healthy Children   Version 2  
Protocol   2019 -06-19 
 
NIH Behavioral and Social Intervention Clinical Trial Protocol Template v3.0 - 20180827  
  24  
Unexpected/Unan ticipated —Not identified in nature, severity, or frequency in the current protocol, informed 
consent, investigator brochure, or with other current risk information.  
 
More Prevalent —Occurs more frequently than anticipated or at a higher prevalence than expe cted.  
 
Serious —Results in death, is life threatening, requires inpatient hospitalization or prolongs existing 
hospitalization, results in persistent or significant disability/incapacity, cancer, overdose, or causes a congenital 
anomaly/birth defect.  
  
The relationship of AE to study particip ation will be determined by the Adverse Monitoring Committee as 
follows.  
 
Unrelated —There is not a reasonable possibility that the adverse event may have been caused by the drug, 
device or intervention.  
 
Possibly Related —The adverse event may have been caused by the drug, device, or intervention,  however 
there is insufficient information to determine the likelihood of this possibility.  
 
Related —There is a reasonable possibility that the adverse event may h ave been caused by the drug, device 
or intervention.  
  
3)  Reporting.  The PI  will responsible for ensuring that all AE  and SAEs are rep orted to the NIH/NINR (Dr. 
Roary) and UNC -CH’s IRB in compliance with their requirements.   
 
Any AE will be reported by the PI to the Adverse Event Monitoring Committee within one week. An incident 
report will be created and sent by electronic email by the PI to Drs. Ammerman, Crandell (Study Staistician), 
Evenson, Faith , Lynn (ISM) Peragallo -Mont ano, Perreira, Perrin , and  the PM. The PI will follow -up with the 
mother and child and will prepare a report. The AEs will be reviewed every three months and a report prepared 
for the Human Participants Committee and Dr. Roary at NIH/NINR. Process notes will be kept concerning any 
decision s.  
 
Any SAE or deaths  that occur  during  the study  will be reported  by telephone  immediat ely to the Hum an 
Participan ts Research  Review  Committee  Chairperson  and Dr. Lynn  (ISM ) and to NIH/NINR  (Dr. Mary Roary) . 
An incident report  will be sent by electronic  mail by the PI to Drs. Ammerman, Crandell, Evenson, Faith , 
Peragallo -Montano, Perreira, Perrin , and  the PM. The PI will follow-up imme diately  with the mother  and child  to 
investigate and  prepare  a report  for all members  of the Human  Participants  Committee and  comply  with all 
regulations  regarding the reporting  of SAEs . If the PI is unavailable,  Dr. Perreira  will be on-call in the PI’s 
absence.  The PI  or Dr. Perreira  in the PI’s absence will be responsible  for complying  with all regulations  
concerning  the reporting  of a SAE and will prepare a full report for NIH/NINR.  It is not expected  that the 
committee  will be involved in the decision  to terminate  the intervention  for a study  participant  related to any 
adverse  event. The PI will meet  with the Study Investigators and the PM and seek input from the Program 
Officer (Dr. Mary Roary) and Dr. Lynn (I SM). Process  notes will be kept concerning  any decisio ns. 
 
4)  Examples of Poten tial Reportable Adverse Events. An AE is reportable is it meets all of the following 
criteria: 1) is unexpected 2) is related and/or possibly related, and 3) is serious and/or suggests that the 
research places subjects or others at a greater risk of physic al or psychological harm than was previously 
known or recognized. Additionally, pe r UNC -CH’s  policy all participant deaths, protocol deviations, complaints 
about the research, and breaches of confidentiality are reportable events.  
 

Healthy Mothers -Healthy Children   Version 2  
Protocol   2019 -06-19 
 
NIH Behavioral and Social Intervention Clinical Trial Protocol Template v3.0 - 20180827  
  25 An example of an AE wou ld be that a 3 -5-year old child decreases from the 25th percentile (normal or healthy 
weight) to below the 5th percentile (underweight) at the next data collection. The steps to be taken i nclude 
withdrawing the child and their mother  from the study . The PI  will immediately contact Dr. Perrin (Pediatrician), 
Dr. Lynn (ISM), the IRB Contact person, and Program Officer Dr. Roary at NIH/NINR. The PI will assist the 
mother to call her Pediatrician and set up an immediate appointment to have her 4 -year old child evaluated 
and ensure that follow -up was received.  
 
An example of an SAE would be the death of a participant from acute renal failure, which although would be 
viewed as unexpected and unrelated to the intervention is nonetheless a reportable serious event.  No further 
steps would be taken except to review, grade and report the event.  
 
5) Safety  Review  Plan . Study  progress  and safety  will be reviewed  monthly  (and more  frequently  if needed).  
Progress  reports, including participant  recruitment,  retention/attrit ion, and AEs will be provided  to Dr.  Lynn  (ISM) 
following  each  of the monthly  reviews.  An annual  report  will be compiled and  will include a list and summary  of 
AEs and SAEs . In addition,  the annual report  will address  (1) whether adverse  event  rates  are consistent  with 
pre-study  assumptions;  (2) reason  for dropouts  from the study; (3)  whether  all participan ts met entry  criteria;  (4) 
whether  conti nuation  of the study  is justified on  the basis  that additi onal data are needed  to accomplish  the 
stated  aims  of the study; and (5) conditions  whereby  the study  might  be terminated  prematurely.  The annual  
report  will be signed  by Dr. Lynn  (ISM) and will be forwarded  to the IRB and NIH/NINR.  The IRB will review 
progress  of this study  on an annual  basis. 
 
SECTION D. Multi -Site Monitoring and Compliance  
This is not a multi -site study.  
  
SECTION E. Assessment of External Factors  
The PI  will conduct a semiannual assessment of external factors through a review of literature related to new 
developments in the areas of wound management, pain, exercise and other approaches that may have an 
impact on the safety of participants or on the ethic s of the study.  
  
SECTION F. Interim Analysis  
The PM will generate semi -annual qualitative interim analysis reports on data obtained during phone call and 
returned end -of-study surveys to understand issues related to the uptake, usability, and adoption of this 
platform among this population. We will evaluate the screening and enrollment procedures, barriers to 
participation and retenti on, acceptability, technology problems encountered if any, and user feedback from the 
participants and providers . This information gained from this structured process will be used to both guide the 
refinement of the current protocol and to inform the design of a larger efficacy trial. There are no planned 
stopping rules for this study.  
 
8.3.3.3  EXPECTEDNESS  
 
N/A 
 
8.3.4  TIME PERI OD AND FREQUENCY FOR EVENT ASSESSMENT AND FOLLOW -UP 
See DSMP above for detail  
8.3.5  ADVERSE EVENT REPORTING  

Healthy Mothers -Healthy Children   Version 2  
Protocol   2019 -06-19 
 
NIH Behavioral and Social Intervention Clinical Trial Protocol Template v3.0 - 20180827  
  26 See DSMP above for detail  
8.3.6  SERIOUS ADVERSE EVENT REPORTING  
See DSMP above for detail  
8.3.7  REPORTING E VENT S TO PARTICIPANTS  
See DSMP above for detail  
8.3.8  EVENTS OF SPECIAL INTEREST  
 
N/A 
 
8.3.9  REPORTING OF PREGNANCY  
 
If a woman becomes pregnant while she is in the study she will be withdrawn and follow -up ensured with her 
obstetric health care provider.  
 
8.4 UNANTICIPATED PROBLEMS  
 
8.4.1  DEFINITION OF U NANTICIPATED PROBLEMS  
See DSMP above for detail  
8.4.2   UNANTICIPATED PROBLEM S REPORTING  
See DSMP above for detail  
8.4.3  REPORTING UNANTICIPATED PROBLEMS  TO PARTICIPANTS  
 
N/A 
9 STATISTICAL CONSIDERATIONS   
9.1 STATISTICAL HYPOTHESES  
Aim 1:  Test the efficacy of the intervention in slowing adiposity and weight  gain trajectory and improving health 
behaviors (nutrition and physical activity) in 4 -year-old Hispanic children from Time 1 (0 months [baseline]) to 
Time 2 (9 months [completion of the intervention]) and Time 1 to Time 3 (15 months [after 6 months with n o 
contact from the study staff]).  

Healthy Mothers -Healthy Children   Version 2  
Protocol   2019 -06-19 
 
NIH Behavioral and Social Intervention Clinical Trial Protocol Template v3.0 - 20180827  
  27 Aim 2:  Test the efficacy of the intervention  in decreasing adiposity and  weight and improving health behaviors 
and self -efficacy in overweight or obese Hispanic mothers from Time 1 to Time 2 and from Time 1 to Time 3.  
Primary outcomes  include slowing of c hild adiposity ( waist circumference and triceps and subscapular 
skinfol ds) and weight gain ( BMI percentile) trajectory and a decrease in mother’s adiposity and weight (BMI). 
We hypothesize  that intervention group childr en will slow the trajectory of adiposity and weight gain and 
intervention group mothers will decrease adiposity and weight significantly more than the control group.  
Secondary outcomes  include c hild and mothers health behaviors (nutrition and physical activit y) and mother’s 
self-efficacy (nutrition and physical activity). We hypothesize  that intervention group children and mothers will 
improve health behaviors and mothers will improve self -efficacy significantly more than the control group.  
Aim 3:  Identify the  media tors through which the intervention influence s the trajectory of adiposity  and weight 
gain in children  and decrease in adiposity and weight in mothers. We hypothesize that h ealth behaviors and 
self-efficacy may mediate adiposity and weight loss in mothers and nutrition and physical activity behaviors in 
children may  mediate  a slower adiposity and weight gain trajectory.   
Aim 4:  Calculate the cost of implementing the interventi on for public health departments  and the costs for 
mothers participating, from Time 1  to Time 2 and compare these costs to the outcomes of the intervention 
(cost -effectiveness) and the potential economic benefits of these outcomes (cost -benefit analysis) . We 
hypothesize  that the intervent ion is primarily focused on knowledge and behaviors in an at -risk population and 
may be cost -effective in comparison wi th other approaches to managing overweight and obesity.  
Exploratory Aim: Determine whether intervention group mothers  in the overweight v ersus obese BMI 
category benefit equally from t he intervention in adiposity, weight, health be haviors, and self -efficacy.     
9.2 SAMPLE SIZE  DETERMINATION  
 
A total of 250 mother -child dyads, or 125 dyads in each randomized group, are expected to complete the 
study. However, we will enroll 294 mother -child dyads (n = 588 participants) or 147 dyads per group, to take 
into account a 15% attrition rate. Our previ ous studies with Hispanic mothers with limited English proficiency 
and their children have had attrition rates ranging from 9% to 15% [23, 33]. Power calculations were performed 
with POWERLIB20 SAS/IML modules, which incorporate methods described in Muller [39]. These methods 
calculate power for a general linear multivariate model that includes repeated measures data structures, of 
which a two -group longitudinal design is a special case. Power was calculated on the use of a separate 
multivariate model for each outcome addressed in the aims, incorporating measurements at all available time 
points. Effect size estimates were based on the pilot data [23], where estimated within -subject correlation and 
standardized mean difference were .25 and .53, respectively, for mothers’ BMI and .30 and .59, respectively, 
for children’s BMI per centiles. For each outcome, power was computed for a test of the time by treatment 
interaction at a two -sided significance level of .05. For an analyzable sample of 125 mother -child dyads per 
group (total of 250 mother -child dyads), calculated statistical power exceeds 95% for both the test of children’s 
BMI percentiles in Aim 1 and the test of mothers’ BMI in Aim 2; if the within subject correlations and 
standardized mean differences are lower than observed in the pilot at .20 and .45, respectively, statis tical 
power will nonetheless exceed 80%. A formal power analysis was not conducted for Aim 3 because the focus 
is on estimation (rather than testing) of direct and indirect mediation effects. Nonetheless, based on Shrout and 
Bolger [40], a sample size of 80 to 85 should provide power in the 70% to 85% range to detect medium effects 
of the intervention on the mediator (e.g., mat ernal self -efficacy), and the mediator on the outcomes (e.g., 

Healthy Mothers -Healthy Children   Version 2  
Protocol   2019 -06-19 
 
NIH Behavioral and Social Intervention Clinical Trial Protocol Template v3.0 - 20180827  
  28 mother’s BMI) with a two sided .05 significance level. Our 250 dyads should provide an adequate sample to 
quantify mediation of the relevant variables.  
9.3 POPULATIONS FOR ANALYSES  
 
Means, standard deviations, minimums, medians, and maximums will be determined for each continuous 
variable; frequencies and percentages will be tabulated for each categorical variable. Preliminary analyses will 
be performed to determine whether, despite randomiz ation, the intervention and control groups were unbalanced 
on gender, age, or income. Any variable with an imbalance between the groups at baseline will be examined to 
determine whether it is related to any of the outcome variables.  If significant relation ships are identified, the 
variable will be included as a covariate in the models for the affected outcome(s) as a potential confounder. An 
intent -to-treat analysis will be used in which all subjects are included in the analysis and analyzed according to 
their initial randomized assignment.  
9.4 STATISTICAL ANALYSES  
9.4.1  GENERAL APPROACH  
9.4.2  ANALYSIS OF THE PRIMARY ENDPOINT(S)  
9.4.3  ANALYSIS OF THE SECONDARY ENDPOINT(S)  
9.4.4  SAFETY ANALYSES  
9.4.5  BASELINE DESCRIPTIVE STATISTICS  
9.4.6  PLANNED INTERIM ANALYSES  
9.4.7  SUB -GROUP ANALYSES  
9.4.8  TABULATION OF IN DIVIDUAL PARTICIPANT DATA  
9.4.9  EXPLORATORY ANALYSES  9.5  
9.4.10  DATA ANALYSIS  
 
Aim 1:  To test the efficacy of the intervention in decreasing trajectory of adiposity and weight gain in 4 -year-old 
children, separate mixed models will be used to test longitudinal differences between the intervention and 
control group means for each outcome ac ross the study period. Mixed effects models, with a random intercept 
to account for between -mother or between -child differences, will be used f or repeated measures analyses  of 
each outcome (child BMI percentile, waist circumference, and triceps and subscap ular skinfolds).  The 
dependent variable will be will be the outcome at each of the three time points; the model will include time point 
(categorical), intervention group, and the interaction between the two.  A test of this interaction will serve as the 
overall test of intervention effect, and step -down tests will be conducted to compare Time 2 and Time 3 to Time 
1, and to estimate how or whether the intervention effect changed from Time 2 to Time 3, using a Hochberg 
correction to account for multiple compa risons  [41, 42]. Results will be summarized t hrough  the least -squares 
means for each group  at each time point and the mean difference and corres ponding 95% confidence interval .  
 
Aim 2:  To test the efficacy of the intervention in decreasing adiposity and weight in mothers, we will fit mixed 
models an alogous to those described for Aim 1 with each of the primary outcomes (mother’s BMI and adiposity 
measures: waist circumference, and triceps and subscapular skinfolds) and secondary outcomes ( child health 
behaviors: nutrition and physical activity, mother’s health behaviors: nutrition and physical activity, and 
mother’s self -efficacy: nutrition and physical activity).  
 
Aim 3:   To identify the mediators through which the intervention influences weight management in mother -child 
dyads , the ap proach  of Shrout and Bolger [40] will be employed. This method, based on bootstrapping , builds 
on establis hed mediation test ing procedures, such as the Baron and Kenny approach [43] and the Sobel test 
[44]. Mediation analyses test pathways by  which an explanatory variable (X) is theorized to influence the 

Healthy Mothers -Healthy Children   Version 2  
Protocol   2019 -06-19 
 
NIH Behavioral and Social Intervention Clinical Trial Protocol Template v3.0 - 20180827  
  29 mediator (M), whic h in turn influences the outcome (Y). Models will be conceptualized for each measure of 
weight and adiposity  for mothers identified in Aim 1 ( Y) and for  each proposed mediator (M), relative to the 
randomized intervention group (X). For each model, an effec t ratio  (defined as the ratio of the indirect effect to 
the total effect, yielding the proportion of the effect that is mediated)  and its bootstrapped distribution will be 
computed to assess the strength of mediation. Mediators (M) to be tested are improvements in health 
behaviors and self -efficacy. For example, we will analyze the effect of the intervention on change in maternal 
self-efficacy from baseline to Time 2, and, in turn the effects of this change in maternal s elf-efficacy at Time 2 
on change in maternal BMI at Time 3.  
 
Sensitivity analyses for Aims 1 -3. Site will be included in all the models, and we will look for evidence of 
differential effects across cohort or site. The primary analyses use all available da ta, but if there is evidence of 
differential missingness by treatment group, we will use imputation methods as a sensitivity analysis.  
 
Aim 4:  We will calculate the incremental cost -effectiveness of the intervention, carried out from society’s 
perspective  as:  
j ij i
ijE EC CCE−−=
 
Where C is cost over the time period of the study; E is effectiveness measured by the outcome s; i refers to the 
intervention and j refers to the control group.   We will calculate cost -effectiveness for the pr incipal outcomes of  
the study; including cost per unit of BMI reduction, and cost per un it of improvement on the nutrition and 
physical activity self -efficacy scales. We will carefully track and calculate the costs of the program intervention 
activities and the control group  activities, in order to measure the differences between the costs in the two 
groups. These costs will include hiring interventionists for all aspects of the Healthy Mothers -Healthy  
Children intervention. We will track the time invested in the program by participants in both the intervention and 
control group and calculate the value of time (opportunity cost) relative to the mothers’ average income.  
 
Exploratory Aim: Analyses will be  performed on weight status, adiposity, health behavior, and self -efficacy to 
explore whether the intervention effects for mothers are similar for  those who are overweight (BMI 25-
29.9kg/m2) and those who are obese ( BMI >30 kg/m2). The mixed models describ ed for Aims 1 and 2 will be 
implemented for each of the weight status, adiposity, health behavior, and self -efficacy variables, with the 
addition of four explanatory variables to each model: an indicator for the obese group , the interaction between 
this indicator and the indicator variable for group membership, the interaction bet ween this indicator and time, 
and the three -way interaction among the group indicator, obese indicator, and time. The hypothesis test for the 
three -way in teraction as well a s the obesity indicator by group indicator interaction jointly equal to zero will 
indicate whether the intervention effects are homogeneous across BMI ranges. For each outcome, differences 
will be calculated to test the effects of the intervention versus c ontrol group at each follow -up point separately 
for each BMI range. Similar analyses will be performed with groupings of children in the 25th-84.9th percentile 
(normal  weight ), 85th-94.9th percentile (overweight) and >95th percentile (obese).   
10 SUPPORTING D OCUMENTATION AND OPERATIONAL CONSIDERATIONS  
10.1 REGULATORY, ETHICA L, AND STUDY OVERSIGHT CONSIDERATIONS  
10.1.1.1            INFORMED CONSENT PROCESS  
10.1.1.2  CONSENT/ASSENT AND OTHER INFORMATIONAL DOCUMENTS PROVIDED TO PARTICIPANTS  
10.1.1.3  CONSENT PROCEDURES AND DOCUMENTATION  
See human subjects section above  for details of consent.  

Healthy Mothers -Healthy Children   Version 2  
Protocol   2019 -06-19 
 
NIH Behavioral and Social Intervention Clinical Trial Protocol Template v3.0 - 20180827  
  30 10.1.2  STUDY DISCONTINUATION AND CLOSURE  
 
At the completion of five years or 60 months the study will be closed unless a no cost extension is needed.  
10.1.3  CONFIDENTIALITY  AND PRIVACY   
 
See Human Subjects above.  
 
Participant confidentiality and privacy is strictly held in trust by the participating in vestigators, their staff, the 
safety and oversight monitor(s), and the sponsor(s)  and funding agency . This confidentiality is extended to the 
data being collected as part of this study. Data that could be used to identify a specific study participant will be 
held in strict confidence within the research team . No personally -identifiable information from the study  will be 
released to any unauthorized third party without prior written approval of the sponsor /funding agency .  
 
All research activities will be conducted in as private a setting as possible.  
 
The study monitor, other authorized representatives of the sponsor  or funding agency , representatives of the 
Institutional Review Board ( IRB), regulatory agencies or representatives from companies or organizations 
supplying  the product , may inspect all documents and records required to be maintained by the investigator for 
the participants in this study.  
 
The study participant’s contact information will be s ecurely stored at the site for internal use during the study. At 
the end of the study, all records will continue to be kept in a secure location for as long a period as dictated by 
the reviewing IRB, Institutional policies, or sponsor /funding agency  requirements.  
 
Study participant research data, which is for purposes of statistical analysis and scientific reporting, will be 
transmitted to and stored on REDCap . This will not include the participant’s contact or identifying information. 
Rather, individual participants and their research data will be identified by a unique study identification number. 
The study data entry and stud y management systems  used by research staff will be secured and password 
protected. At the end of the study, all study databases will be de -identified and archived at the University of North 
Carolina at Chapel Hill School of Nursing . 
 
Measures Taken to Ens ure Confidentiality  of Data Shared per  the NIH Data Sharing Policies  
It is NIH policy that the results and accomplishments of the activities that it funds should be made available to 
the public (see  https://grants.nih.gov/policy/sharing.htm ). The PI will ensure all mechanisms used to share data 
will include proper plans and safeguards for t he protection of privacy, confidentiality, and security for data 
dissemination and reuse  (e.g., all data will be thoroughly de -identified and will not be traceable to a specific study 
participant) . Plans for archiving and long -term preservation of the data  will be implemented, as appropriate.  
 
Certificate of Confidentiality  
To further protect the privacy of study participants, the Secretary, Health and Human Services (HHS), has issued 
a Certificate of Confidentiality (CoC) to all researchers engaged in bi omedical, behavioral, clinical or other human 
subjects research funded wholly or in part by the federal government.   Recipients of NIH  funding for  human 
subjects research are required to protect identifiable research information from forced disclosure per the terms 
of the NIH Policy (see https://humansubjects.nih.gov/coc/index ). As set forth in  45 CFR Part 

Healthy Mothers -Healthy Children   Version 2  
Protocol   2019 -06-19 
 
NIH Behavioral and Social Intervention Clinical Trial Protocol Template v3.0 - 20180827  
  31 75.303(a)  and NIHGPS Chapter 8.3 , recipients condu cting NIH -supported research covered by this Policy are 
required to establish and maintain effective internal controls (e.g., policies and procedures) that provide 
reasonable assurance that the award is managed in compliance with Federal statutes, regulati ons, and the terms 
and conditions of award. It is the NIH policy that investigators and others who have access to research records 
will not disclose identifying information except when the participant consents or in certain instances when federal, 
state, o r local law or regulation requires disclosure. NIH expects investigators to inform research participants of 
the protections and the limits to protections provided by a Certificate issued by this Policy.  
10.1.4  FUTURE USE OF STORED SPECIMENS  AND DATA   
 
Data collec ted for this study will be analyzed and stored at the University of North Carolina School of Nursing . 
After the study is completed, the de -identified, archived data will be tr ansmitted to and stored at the University 
of North Carolina School of Nursing , for use by other researchers including those outside of the study.  
 
10.1.5  KEY ROLES  AND STUDY GOVERNANCE  
 
Principal Investigator  Medical Monitor  or 
Independent Safety Monitor  
Dr. Hudson Santos  Dr. Mary Lynn  
The University of North Carolina 
at Chapel Hill   The University of North 
Carolina at Chapel Hill   
Campus Box 7460  Campus Box 7460  
919-259-4812  919-966-5450  
hsantosj @email.unc.edu  Mary_Lynn@unc.edu  
 
See DSMP Above  
10.1.6  SAFETY OVERSIGHT  
 
Safety oversight will be under the direction of a Data and Safety Monitoring Plan (DSMP)  composed of individuals 
with the appropriate expertise. See the DSMP for details.  
 
10.1.7  CLINICAL MONITORING  
 
N/A 
 
10.1.8  QUALITY ASSURANCE AND QUALITY CONTROL  
Procedures will be followed according to standard protocols for height, weight, calculation of BMI and BMI 
percentile and collection of anthropometric measurements and questionnaire and accelerometry and 24 hour 
food recall data.  
Quality control ( QC) procedures will be implemented as follows:  

Healthy Mothers -Healthy Children   Version 2  
Protocol   2019 -06-19 
 
NIH Behavioral and Social Intervention Clinical Trial Protocol Template v3.0 - 20180827  
  32  
Informed consent  --- Study staff will review both the documentation of the consenting process as well as a 
percentage of the completed consent documents.  This review will evaluate compliance with GCP, accuracy, 
and completeness.  Feedback will be provided to the study team to ensure proper consenting  procedures are 
followed .  
 
Source documents  and the electronic data --- Data will be initially captured on source documents and will 
ultimately be entered into the study database .  To ensure accuracy site staff will compare a representative 
sample of source data against the database, targeting key data points in that review.  
 
Intervention Fidelity  — Consistent delivery of the study interventions will be monitored throughout the 
intervention phase of the study. Procedures for ensuring fidelity of interve ntion delivery are described above.  
 
Protocol Deviations  – The study team will review protocol deviations on an ongoing basis and will implement 
correctiv e actions when the quantity or nature of deviations are deemed to be at a level of concern.  
 
Should independent monitoring become necessary, t he PI will provide direct access to all trial related sites, 
source data/documents, and reports for the purpose of  monitoring and auditing by the sponsor /funding agency , 
and inspection by local and regulatory author ities. 
 
10.1.9  DATA  HANDLING  AND  RECORD  KEEPING   
 
10.1.9.1  DATA COLLECTION AND  MANAGEMENT RESPONSIBILITIES  
 
Data collection will be  the responsibi lity of the Principal Investigator  at the site un der the supervision of the 
Project Manager . The investigator will be  responsible for ensuring the accuracy, completeness, legibility, and 
timeliness of the data reported.  
 
All source documents will be completed in a nea t, legible manner to ensure accurate interpretation of data.   
 
Hardcopies of the study visit worksheets  will be provided for use as source document  worksheets for recording 
data for each participant consented/ enrolled in the study.  Data recorded in the electronic case report form 
(eCRF ) derived from source documents will be consistent with the data recorded on the source documents .  
 
Clinical data will be entered into REDCap , a 21 CFR Part 11 -compliant data capture system provided by the 
University of No rth Carolina at Chapel Hill . The data system includes password protection and internal quality 
checks, such as automatic range checks, to identify data that appear inconsistent, incomplete, or inaccurate. 
Clinical data will be entered directly from the sou rce documents.  
 
 
 
10.1.9.2  STUDY RECORDS RETENTION  

Healthy Mothers -Healthy Children   Version 2  
Protocol   2019 -06-19 
 
NIH Behavioral and Social Intervention Clinical Trial Protocol Template v3.0 - 20180827  
  33  
Study documents will be retained for a minimum of 5  years .  
10.1.10  PROTOCOL DEVIATIONS   
 
This protocol defines a protocol deviation a s any noncompliance with the clinical trial protocol, International 
Council on Harmonisation.  The noncompliance may be either on the part of the participant, the investigator, or 
the study site staff. As a result of deviations, corrective actions will be developed by the site and implemented 
promptly.  
 
10.1.11  PUBLICATION AND DATA SHARING POLICY   
 
This study will  be conducted in accordance with the following  publication and data sharing  policies and 
regulations:  
 
National Institutes of Health ( NIH) Public Access Policy, which ensures that the public has access to the 
published results of NIH funded research. It requires scientists to submit final peer -reviewed journal manuscripts 
that arise from NIH funds to the digital archive PubMed Central  upon a cceptance for publication.  
 
This study will comply with the NIH Data Sharing Policy and Policy on the Dissemination of NIH -Funded Clinical 
Trial Information and the Clinical Trials Registration and Results Information Submission r ule. As such,  this trial 
will be registered at ClinicalTrials.gov , and results information from this  trial will be submitted to ClinicalTrials.gov.  
In addition, every attempt will be made to publish results in peer -reviewed journals.  Data from this study may 
be request ed from other researchers 5  years after the completion of the primary  endpoint by contacting the 
Principal Investigator .   
10.1.12  CONFLICT O F INTEREST  POLICY  
 
The independence of this study from any actual or perceived influence, such as by the pharmaceutical industry, 
is critical . Therefore , any actual conflict of interest of persons who have a role in the design, conduct, analysis, 
publicati on, or any aspect of this trial will be disclosed and managed. Furthermore, persons who have a perceived 
conflict of interest will be required to have such conflicts managed in a way that is appropriate to their participation 
in the design and conduct of this t rial. The study leadership in conjunction with the NINR has established policies 
and procedures for all study group members to disclose all conflicts of interest and will establish a mechanism 
for the management of all reported dualities o f interest.  
10.2 ADDITIONAL CONSIDERATIONS  
N/A 
10.3 ABBREVIATIONS AND SPECIAL TERMS  
 
AE Adverse Event  
CFR Code of Federal Regulations  
COC  Certificate of Confidentiality  

Healthy Mothers -Healthy Children   Version 2  
Protocol   2019 -06-19 
 
NIH Behavioral and Social Intervention Clinical Trial Protocol Template v3.0 - 20180827  
  34 CONSORT  Consolidated Standards of Reporting Trials  
CRF Case Report Form  
DHHS  Department of Health and Human Services  
DSMB  Data Safety Monitoring Board  
EC Ethics Committee  
eCRF  Electronic Case Report Forms  
FDA Food and Drug Administration  
FDAAA  Food and Drug Administration Amendments Act of 2007  
FFR Federal Financial Report  
GCP Good Clinical Practice  
HIPAA  Health Insurance Portability and Accountability Act  
IB Investigator’s Brochure  
ICH International Council  on Harmonisation   
ICMJE  International Committee of Medical Journal Editors  
IRB Institutional  Review Board  
ISM Independent Safety Monitor  
ITT Intention -To-Treat  
NCT National Clinical Trial  
NIH  National Institutes of Health  
NIH IC  NIH Institute or Center  
OHRP  Office for Human Research Protections  
PI Principal Investigator  
QA Quality Assurance  
QC Quality Control  
SAE Serious Adverse Event  
SAP Statistical Analysis Plan  
SMC  Safety Monitoring Committee  
SOA  Schedule of Activities  
SOP Standard Operating Procedure  
UP Unanticipated Problem  
US United States  
 
  

Healthy Mothers -Healthy Children   Version 2  
Protocol   2019 -06-19 
 
NIH Behavioral and Social Intervention Clinical Trial Protocol Template v3.0 - 20180827  
  35 10.4 PROTOCOL  AMENDMENT  HISTORY  
 
Version  Date  Description of Change  Brief Rationale  
2 2019 -06-
19 Updated to include 3 -5 year old 
children  Increase sample  
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
  

Healthy Mothers -Healthy Children   Version 2  
Protocol   2019 -06-19 
 
NIH Behavioral and Social Intervention Clinical Trial Protocol Template v3.0 - 20180827  
  36 11 REFERENCES  
 
1. Ogden, C.L., et al., Prevalence of childhood and adult obesity in the United States, 2011 -2012.  Journal 
of the American Medical Association, 2014. 311(8): p. 806 -814. 
2. American Diabetes Association, American Diabetes Association Standards of Medical Care in Diabetes -
2016.  Diabetes Care, 2016. 39(1): p. S1 -S112.  
3. American Heart Association Statistics Committee and Stroke Statistics Subcommittee, Heart Disease 
and Stroke  Statistics -2016 Update.  Circulation, 2016. 133(4): p. e38 -360. 
4. Finkelstein, E.A., et al., Annual medical spending attributable to obesity: payer -and service -specific 
estimates.  Health Affairs, 2009. 28: p. 822 -831. 
5. Finkelstein, E.A., W.C. Graham, an d R. Malhotra, Lifetime direct medical costs of childhood obesity.  
Pediatrics, 2014. 133(5): p. 854 -862. 
6. Stepler, R. and A. Brown, Statistical Portrait of Hispanics in the United States . Pew Research Center. 
2014, Washington, D.C.: Pew Research Center.  
7. Berry, D., et al., Latino caregiver's insight into childhood overweight, management and their relationship 
with their health care providers.  Hispanic Health Care International, 2009. 7: p. 11 -20. 
8. Berrigan, D., et al., Physical activity and acculturat ion among adult Hispanics in the United States.  
Research Quarterly Exercise and Sports, 2006. 77(2): p. 147 -157. 
9. Batis, C., et al., Food Acculturation Drives Dietary Differences among Mexicans, Mexican Americans, 
and Non -Hispanic Whites.  Journal of Nutr ition, 2011. Aug 31. [Epub ahead of print] . 
10. Powell, L.M., et al., Food store availabiltiy and neighborhood characteristics in the United States.  
Preventive Medicine, 2007. 44(3): p. 189 -195. 
11. Ham, S.A., et al., Physical activity patterns among Latin os in the United States: putting the pieces 
together.  Prevention of Chronic Disease, 2007. 4: p. 1 -13. 
12. Bautista, L., et al., Perceived barriers to exercise in Hispanic adults by level of activity.  Journal of Physical 
Activity and Health, 2011. 8(7): p. 916 -925. 
13. Advertising Age, 2016 Hispanic Fact Pack.  Ad Age Research Reports, 2016: p. 1 -36. 
14. Rideout, V., U. Foehr, and D. Roberts, Geberation M2 : media in the lives of 8 -to-18 year olds . 2010, 
Menlo Park, CA: The Henry J. Kaiser Family Foundation.  
15. Delva, J., L.D. Johnston, and P.M. O'Malley, The epidemiology of overweight and related lifestyle 
behaviors: racial/ethnic and socioeconomic status  differences among American youth.  Am J Prev Med, 
2007. 33(4 Suppl): p. S178 -86. 
16. Wiecha, J.L., et al., When children eat what they watch: impact of television viewing on dietary intake in 
youth.  Archives of Pediatrics and Adolescent Medicine, 2006. 160(4): p. 436 -442. 

Healthy Mothers -Healthy Children   Version 2  
Protocol   2019 -06-19 
 
NIH Behavioral and Social Intervention Clinical Trial Protocol Template v3.0 - 20180827  
  37 17. Thompson, J.L., et al., Physically active families - de-bunking the myth? A qualitative study of family 
participation in physical activity.  Child Care Health and Development, 2009 Dec 29. [Epub ahead of print].  
18. Patrick, H. and T.A.  Nicklas, A review of family and social determinants of children's eating patterns and 
diet quality.  Journal of the American College of Nutrition, 2005. 24(2): p. 83 -92. 
19. Oude Luttikhuis, H., et al.,  Interventions for treating obesity in children.  Cochr ane Database of Systematic 
Reviews 2009, 2009(1): p. Art. No.: CD001872. DOI: 10.1002/14651858.CD001872.pub2.  
20. Lindsay, A.C., K.M. Sussner, and S. Gortmaker, The role of parents in preventing childhood obesity.  
Future Child, 2006. 16(1): p. 169 -186. 
21. Hoghughi, M. and N. Long, Handbook of parenting: theory and research for practice . 1st ed. 2004, 
London: Sage.  
22. Berk, L., Child Development . 8th ed. 2008, Upper Saddle River, New Jersey: Pearson Higher Education.  
23. Berry, D., et al., Adapting, feasib ility testing, and pilot testing a weight management intervention for 
recently immigrated Spanish -speaking women and their 2 -to-4 year old children.  Hispanic Health Care 
International 2011. 9: p. 186 -193. 
24. Campbell, K., et al., Interventions for prevent ing obesity in children: Cochrane review . 2004, Wiley: 
Oxford. p. 1 -37. 
25. Summerbell, C.D., et al., Interventions for preventing obesity in children. Cochrane reviews.  Cochrane 
Database of Systematic Reviews, 2005(3): p. Art. No.: CD001871. DOI: 
10.1002/ 14651858.CD001871.pub2.  
26. Dunn, C., C. Thomas, and L. Pegram, Color Me Healthy: Preschoolers moving and eating healthy . 2006, 
Raleigh, North Carolina: North Carolina State University.  
27. Bandura, A., Social learning theory . 1977, Englewood Cliffs, NJ: P rentice -Hall. 
28. Bandura, A., Self-efficacy mechanism is human agency.  American Psychologist, 1982. 37: p. 122 -147. 
29. Bandura, A., Social foundations of thought and action: A social cognitive theory . 1986, Englewood Cliffs, 
NJ: Prentice Hall.  
30. Bandura, A., Self-efficacy: The exercise of control . 1997, New York: W.H. Freeman.  
31. Bandura, A., Health promotion by social cognitive means.  Health Education and Behavior, 2004. 31(12): 
p. 143 -164. 
32. Berry, D.C., et al., Rationale, design, and methodo logy for the optimizing outcomes in women with 
gestational diabetes mellitus and their infants study.  BMC Pregnancy Childbirth, 2013. 13: p. 184.  
33. deRosset, L., et al., Mama sana ... usted sana: lessons learned from a postpartum weight loss 
intervention  for Hispanic women with infants six months or less.  Hisp Health Care Int, 2013. 11(2): p. 78 -
86. 
34. Motel, S. and C. Patten, The 10 largest Hispanic origin groups: characteristics, rankings, top counties . 
2012, Pew Hispanic Center.  

Healthy Mothers -Healthy Children   Version 2  
Protocol   2019 -06-19 
 
NIH Behavioral and Social Intervention Clinical Trial Protocol Template v3.0 - 20180827  
  38 35. Marín, G., et al.,  Development of a short acculturation scale for Hispanics.  Hispanic Journal of Behavioral 
Sciences, 1987. 9: p. 183 -205. 
36. Berry, D.C., et al., Rationale, design, methodology and sample characteristics for the family partners for 
health study: a cluster randomized controlled study.  BMC Public health, 2012. 12: p. 250.  
37. Berry, D.C., et al., The family partners for health study: a cluster randomized controlled trial for child and 
parent weight management.  Nutr Diabetes, 2014. 4: p. e101.  
38. Bellg, A.J.,  et al., Enhancing treatment fidelity in health behavior change studies: best practices and 
recommendations from the NIH Behavior Change Consortium.  Health Psychology, 2004. 23(5): p. 443 -
451. 
39. Muller, K.E., et al., Power calculations for general linear multivariate models including repeated measures 
applications.  Journal of the American Statistical Association, 1992. 87: p. 1209 -1226.  
40. Shrout, P.E. and N. Bolger, Mediation in experimental and nonexperimental studies: new procedures and 
recommen dations.  Psychological Methods, 2002. 7(4): p. 422 -445. 
41. Mallinckrodt, C.H., et al., Recommendations for the primary analysis of continuous endpoints in 
longitudinal clinical trials.  Drug Information Journal, 2008. 42: p. 303 -319. 
42. Mallinckrodt, C.H., et al., Assessing and interpreting treatment effects in longitudinal clinical trials with 
missing data.  Biological Psychiatry, 2003. 53: p. 754 -760. 
43. Baron, R. and D. Kenny, The moderator -mediator variable distinction in social psych ological research:  
Conceptual, strategic, and statistical considerations.  Journal of Personality and Social Psychology, 1986. 
51(6): p. 1173 -1182.  
44. Sobel, M.E., Aymptomatic confidence intervals for indirect effects in structural equation models , in 
Sociological Methodology , S. Leinhardt, Editor. 1982, American Sociological Association: Washington, 
DC. 
 
 
